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“Even if it Breaks Your Heart” 
Eli Young Band 
Way back on the radio dial, 
The fire got lit inside a bright-eyed child 
Every note just wrapped around his soul, 
From steel guitars to Memphis, all the way to rock and roll 
 
Oh, I can hear ‘em playin’ 
I can hear the ringin’ of a beat up ol guitar 
Oh, I can hear singin’ 
“Keep on dreamin’ even if it breaks your heart” 
 
Downtown is where I used to wander 
Old enough to get there but too young to get inside 
So I would stand out on the sidewalk,  
Listen to the music playin’ every Friday night 
 
Oh, I can hear ‘em playin’ 
I can hear the ringin’ of a beat up ol guitar 
Oh, I can hear singin’; 
“Keep on dreamin’ even if it breaks your heart” 
 
Some dreams stay with you forever,  
Drag you around and bring you back to where you were 
Some dreams keep on gettin’ better 
Gotta keep believin’ if you wanna know for sure 
 
Oh, I can hear ‘em playin’ 
I can hear the ringin’ of a beat up ol guitar 
Oh, I can hear singin’; 
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Spotted Fever Group Rickettsia are inoculated into the mammalian host during 
hematophagous arthropod feeding. Once in the bloodstream and during dissemination, the survival 
of these pathogens is dependent upon their ability to evade innate host defenses until a proper 
cellular target is reached. The establishment of a successful infection also relies on the ability of 
the bacteria to attach and invade target cells, as failure to do so results in destruction of the 
bacterium.  Rickettsia conorii expresses an outer membrane protein, Adr1, which binds the 
multifunctional human glycoprotein, vitronectin, to promote resistance to complement mediated 
killing. Homologs of Adr1 are present in all sequenced pathogenic Rickettsia species to date, 
suggesting that the ability to sequester vitronectin is a conserved attribute for this genus of bacteria. 
The ultimate goal of my dissertation research was to define the roles of vitronectin acquisition by 
R. conorii in rickettsial pathogenesis. Herein, I characterize the Adr1/vitronectin interaction, 
demonstrating that this beneficial protein-protein interaction is a heparin-independent, electrostatic 
interaction that is mediated by the C-terminal region of human vitronectin. By utilizing site-
directed mutagenesis, I was able to identify specific amino acids within the Adr1 protein that form 
interaction with the multimeric form of vitronectin for protection from complement mediated 
killing.  I subsequently employed exogenous vitronectin to examine the role of vitronectin in 
adherence and invasion of R. conorii into phagocytic and endothelial cells. Interestingly, the 
presence of vitronectin increased the ability of the bacteria to invade monocytes but decreased the 
ability of the bacteria to invade endothelial cells. In summary, my findings demonstrate a dual role 
for vitronectin acquisition in rickettsial pathogenesis. This knowledge will be useful to specifically 
target the R. conorii/vitronectin/host cell interaction for the development of potential prophylactic 




INTRODUCTION AND LITERATURE REVIEW 
 
 
1.1 Rickettsia and Disease 
Bacteria of the genus Rickettsia are small (0.3 to 0.5 μm by 0.8 to 1.0 μm), obligate, 
intracellular, Gram-negative, -proteobacteria, many of which are clinically relevant human 
pathogens. (Paddock, 2012; Riley et al., 2012).  Mammalian hosts become infected when an 
arthropod vector, such as a tick, flea or mite takes a blood meal (Azad and Beard, 1998).  Rickettsia 
can be found on every continent except Antarctica and are responsible for a number of emerging 
infectious diseases worldwide (Paddock, 2012).  Traditionally, rickettsia taxonomy is derived by 
sequence analysis of various genes including house-keeping genes and immunodominant outer-
membrane proteins (Gillespie et al., 2008; Walker and Ismail, 2008). Currently, the bacteria are 
divided into four groups based on their biological, genetic and antigenic characteristics: the spotted 
fever group (SFG); the typhus group (TG); the transitional group (TRG); and the ancestral group 
(AG) (Walker and Ismail, 2008).   Members of the SFG, TG and TRG have been associated with 
human infections and are responsible for a number of significant human diseases including Rocky 
Mountain Spotted Fever, Mediterranean Spotted Fever and Epidemic Typhus (Azad and Beard, 
1998).  
Rickettsia are maintained in an enzoonotic cycle between humans, mammals, birds, and 
hematophagous arthropods (Ceraul, 2012). SFG Rickettsia are transmitted by the family of hard 
ticks known as Ixodidae while TG and TRG Rickettsia are transmitted by fleas, lice and mites 
(Raoult and Roux, 1997).  Ticks that carry rickettsia can act as both vector and reservoir and 
distribution of the bacteria is limited to the distribution and seasonality of the tick.  (Raoult and 
Roux, 1997; Azad and Beard, 1998).  The tick host can acquire and maintain a rickettsial infection 
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vertically by transovarial and transstadial transmission, or horizontally, by feeding on a 
rickettsemic host (Burgdorfer and Brinton, 1975; Walker and Ismail, 2008). After transmission of 
the bacteria to a tick, the bacteria can infect and multiply in almost all tissues of the tick, including 
the salivary glands and ovaries (Raoult and Roux, 1997).  Infected ticks can then transmit SFG 
Rickettsia to a mammalian host via inoculation of bacteria into the host during a blood meal 
(McGarry, 2011). The relationship between rickettsiae and tick is not always mutually beneficial. 
Some species of rickettsia, such as Rickettsia peacockii are maintained within the tick population 
as an endosymbiont, while others are detrimental to their tick host’s fitness (Harris et al., 2017).  
Pathological effects in ticks have been described for R. rickettsii infection of Dermacentor 
andersoni, Dermacentor variablis and Amblyomma americanum (Burgdorfer and Brinton, 1975).  
This suggests that both mammalian and tick reservoirs play a crucial role in maintenance of 
pathogenic rickettsia species in nature.   
TG and TRG Rickettsia are associated with blood sucking insects and arthropods such as 
human body lice, fleas and mites. Because these insects are intermittent feeders and are capable of 
multiple feedings, they have the potential to spread rickettsiae rapidly among susceptible 
populations causing massive outbreaks of disease (Azad and Beard, 1998).  Reservoirs for TG and 
TRG Rickettsia include mammals such as small rodents and humans.  Unlike ticks which can serve 
as both reservoirs and vectors for SFG Rickettsia mites act only as vectors for TG and TRG 
rickettsial species.  After uptake of bacteria during a blood meal on a rickettsemic host, the bacteria 
infect the lining of the gut and are eventually shed in the feces.  Transmission of the bacteria to 
mammalian host occurs by contamination of the bite site with feces shed from the infected insect 
which can remain infective for years (Raoult and Roux, 1997).   
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Rickettsia species include some of the most pathogenic bacteria known and as a result they 
have had a profound impact on human lives over the centuries (Paddock, 2012). The first recorded 
outbreak of rickettsial infection occurred during the Siege of Naples in 1529 (Walker and Ismail, 
2008).  The bacterium responsible for this outbreak was later determined to be R. prowazekii, the 
causative agent of epidemic typhus. Throughout the next five centuries, typhus continued to 
devastate human populations, especially those grouped closely together or displaced by war 
(Paddock, 2012). During World War I, approximately 30 million people in Russia were afflicted, 
of which, 3 million perished (Walker and Ismail, 2008). Typhus is also suspected to be a major 
contributing factor to soldier deaths in the Napoleonic war and the war of Spanish succession from 
1710 to 1712 (Paddock, 2012).  
 RMSF and MSF which are caused by infection with R. rickettsii and R. conorii 
respectively, have been described since the beginning of the 20th century (Parola and Raoult, 2006).  
As reported by Parola et al. (2005), the first clinical appearance of the disease was described by 
Edward E. Maxey in 1899 (Parola et al., 2005).  Then in 1906, Howard T. Ricketts traveled to the 
Bitterroot Valley in Montana to study a disease known as black measles  (Ricketts, 1906a).  
Ricketts and his assistant demonstrated that black measles, also known as spotted fever, was a tick-
borne disease (Ricketts, 1906b; 1907; Gross and Schafer, 2011). The team would go on to study 
typhus in Mexico where they would isolate the bacterium responsible for illness in the blood of a 
patient.  Unfortunately, this discovery would ultimately lead to Ricketts infection and cause his 
untimely death.  Due to his pioneering work in the field, the shared genera of organisms were later 
named after him (Wolbach, 1919; Gross and Schafer, 2011). 
RMSF and MSF are considered two of the most severe diseases (Lin and Decker, 2012).  
Infection with the bacterium can cause a wide range of clinical symptoms usually involving fever, 
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headache, and the characteristic macropapular rash.  The rash begins on the extremities, such as 
the wrist and ankles, and moves toward the trunk of the body indicating systemic infection (Drexler 
et al., 2016).  In MSF, an eschar, defined as a small, non-pruitic lesion surrounded by an 
erythematous halo where bacteria and immune cells are can be found in approximately 72% of 
cases present (Paddock et al., 2004; Oteo and Portillo, 2012).  If left untreated, infection can lead 
to increased morbidity and potentially death (Walker and Ismail, 2008).  The incubation period 
from tick bite to initial onset of symptoms occurs between 2 and 14 days with a rash occurring in 
most patients 3 to 5 days after the onset of fever (Lin and Decker, 2012).  When properly 
diagnosed, treatment with the antibiotic doxycycline, is generally successful with less than a 1% 
mortality rate; however, if left untreated the fatality rate may be as high as 20 to 25% (Drexler et 
al., 2016).   
R. parkerii, a pathogenic rickettsial species closely related to R. rickettsii, has also been 
shown to cause human illness within the United States (Drexler et al., 2016).  Infection with R. 
parkerii can be distinguished from R. rickettsii by the presence of an eschar at the site of tick 
attachment (Paddock et al., 2004; Paddock et al., 2008).  TG Rickettsia infection is characterized 
by similar symptomology to RMSF and MSF.  Patients experience fever, headache, mental 
confusion and rash (Walker and Ismail, 2008).  If left untreated, typhus can lead to life-threatening 
complications and eventually death in formerly healthy individuals (Walker and Ismail, 2008).   
Rickettsia are obligate, intracellular bacteria and as such can only replicate in the nutrient-
rich cytoplasm of the host cell where they have access to the biosynthetic precursors required for 
growth and survival. The bacteria are capable of infecting cells of many origins, including 
endothelial cells, monocytes, macrophages and hepatocytes  (Walker and Gear, 1985; Walker and 
Dumler, 1994; Walker, 1997; Walker et al., 1999; Chan et al., 2010; Riley et al., 2010; Curto et 
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al., 2016).  Disease pathogenesis is generally thought to be associated with infection of the 
endothelium and the subsequent damage to the lining of the blood vessels.  This results in 
generalized vascular inflammation, loss of vascular integrity and increased vascular permeability, 
termed Rickettsial vasculitis (Walker and Ismail, 2008; Sahni and Rydkina, 2009).  Disruption of 
the endothelial lining leads to increased fluid leakage which causes the distinctive dermal rash 
(Walker and Ismail, 2008).  Widespread damage to the endothelium can lead to severe 
manifestations of the disease including encephalitis, which leads to delirium, coma and seizures, 
non-cardiogenic pulmonary edema, interstitial pneumonia, hypovolemic shock, renal failure and 
occasionally multi-organ failure and disseminated intravascular coagulation (Walker and Ismail, 
2008; Sahni and Rydkina, 2009).   
In addition, infection of the endothelium results in endothelial cell activation, production 
of pro-inflammatory cytokines, oxidative stress and inhibition of apoptosis (Walker and Ismail, 
2008; Sahni and Rydkina, 2009).  Endothelial activation is characterized by functional changes in 
the cell including increased adhesiveness for platelets, increased expression of intracellular and 
vascular cell-adhesion molecules (I-CAM and V-CAM), and E-selectin, as well as increased 
production of plasminogen activator inhibitor-1 (Silverman, 1986; Teysseire et al., 1992; Sporn et 
al., 1994; Kaplanski et al., 1995; Sporn and Marder, 1996).  Infection also induces translocation 
of nuclear-factor-kappaB (NF-κB) from the cytoplasm to the nucleus of the cell which leads to 
increased gene expression of pro-inflammatory cytokines and chemokines such as IL-1α, IL-6, IL-
8, and chemoattractant protein-1 (Shi et al., 1998; Joshi et al., 2004; Sahni and Rydkina, 2009). 
This pro-inflammatory response is linked to preservation of mitochondrial integrity, prevention of 
the caspase cascade and inhibition of apoptosis of rickettsia infected cells, therefore promoting 
bacterial survival and replication (Clifton et al., 1998; Sahni et al., 2013). Endothelial cell infection 
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also leads to accumulation of intracellular peroxides and superoxide radicals, increased amounts 
of extracellular H2O2, reduction in the levels of cellular thiols and alterations in the activities of 
important antioxidant enzymes resulting in loss of osmoregulatory control and cell lysis (Sahni 
and Rydkina, 2009).   
Although endothelial cells have been previously considered the main target for rickettsial 
infection, macrophages, monocytes and hepatocytes have also been identified as major cellular 
targets (Walker and Gear, 1985; Walker et al., 1994; Walker, 1997; Walker et al., 1999; Cardwell 
and Martinez, 2009; Chan et al., 2010; Riley et al., 2010).  Recent studies involving C3H/HeN 
mice and Rhesus Macaques models of SFG Rickettsia infection demonstrated evidence of bacteria 
located with the cytoplasm of macrophages and neutrophils both in circulation and in tissues  
(Banajee et al., 2015; Curto et al., 2016; Riley et al., 2016).  This data suggests that interaction of 
rickettsiae with non-endothelial cells contributes to disease pathogenesis although the mechanisms 
have yet to be elucidated.  To date, there is no commercially available vaccine in place to protect 
against rickettsial infections.  Several potential targets have been recognized, however a 
universally protective antigen has yet to be identified.  Elucidation of the mechanisms of 
interaction between rickettsia and newly idenfitied target host cells could potentially lead to novel 
and efficacious targets of anti-rickettsial therapies.  
1.2 Complement and Complement Proteins 
The complement system is the first line of defense against invading pathogenic microbes 
and is continuously surveying the human body for intruders in a highly efficient manner.  It is 
considered part of the innate immune system and serves as a bridge to adaptive immunity (Walport, 
2001a).  The system is comprised of more than 30 surface-expressed and soluble proteins, many 
of which circulate as inactive precursors that require cleavage to become active enzymes (Mathern 
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and Heeger, 2015).  Complement can be activated via three different pathways: classical; lectin 
and alternative pathways, which converge at the formation of C3 convertase to form the common 
terminal membrane attack complex (Figure 1.1) (Liszewski and Atkinson, 2015).  The classical 
pathway is activated upon recognition of antigen-bound antibody by the C1 complex.  This causes 
a conformational change in the C1 complex which results in cleavage of C4 and C2 to their 
respective parts (C4a, C4b, C2a and C2b).  C4b then binds to cell surfaces and recruits C2b to 
form the C4bC2b classical pathway C3 convertase (Mathern and Heeger, 2015).  The lectin 
pathway functions in a similar manner.  Mannose binding lectins (MBL) bind to bacterial 
carbohydrate motifs which activate MBL-associated proteases.  These proteases then cleave C4 
and C2 eventually yielding C4bC2b MBL C3 convertase on the cell surface (Mathern and Heeger, 
2015).  Alternative pathway activation occurs spontaneously and continuously at a low rate.  The 
mechanism involves C3 associating with a water molecule to give C3(H20).  This complex recruits 
factor B (fB) and factor D (fD).  fD then cleaves fB and C3 generating molecules Bb, C3a and 
C3b. C3b binds to the surface of a cell and associates with Bb to form C3bBb alternative pathway 
C3 convertase (Mathern and Heeger, 2015).  Upon formation of C3 convertase by the 
aforementioned pathways, the enzyme cleaves additional C3 molecules forming an amplification 
loop.  This rapidly increases formation of C3 convertase in the blood and in the absence of 
regulation results in a high concentration of surface deposited C3b that is critical for 









Figure 1.1. Overview of the complement cascade.  The complement cascade can be activated 
via three different mechanisms: the classical pathway, the mannose binding lectin (MLB) 
pathway or the alternative pathway which converge at the formation of C3 convertease to form 
the common lytic pathway.  The resulting C3 convertase cleaves C3 into C3a and C3b and also 
forms an amplification loop generating more C3 convertase.  The C3 convertases then 
associated with C3b to form the C5 convertease which cleaves C5 into C5a and C5b.  C5b 
associates with C6, C7, C8 and C9 to form a membrane spanning pore termed the membrane 
attack complex (MAC).  This complex inserts into the cell membrane resulting in cell lysis 
(Hallstrom and Riesbeck, 2010).   
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Regardless of the initiating pathway, terminal complement complex formation is initiated 
when C3 convertase (C4bC2b or C3bBb) binds an additional C3b molecule producing the highly 
unstable C5 convertase (C4bC2bC3b or C3bBbC3b) (Mathern and Heeger, 2015).  This volatile 
enzyme then cleaves C5 into C5a and C5b, of which C5b proceeds to sequentially bind C6, C7, 
C8 and multiple C9 molecules to form the membrane attack complex (MAC).  The MAC then 
inserts into the target cell membrane forming a pore which results in cell lysis (Zipfel et al., 2013).   
Complement not only functions in direct lysis of target cells, but various other complement 
cleavage products have effector functions that promote immune system activation and clearance 
of pathogens.  C3a and C5a binds to cells bearing the C3a and C5a receptors, such as neutrophils 
and macrophages, to activate the cell, induce production of pro-inflammatory cytokines and 
chemokines and increase chemotactic activity (Zipfel et al., 2013).   In addition, C3a also possesses 
anti-microbial activity against both Gram-negative and Gram-positive bacteria and fungi (Zipfel 
et al., 2013).  Activation of macrophages by complement promotes intracellular killing of engulfed 
organisms and contributes to T-cell and other antigen-presenting cell activation, expansion and 
survival (Mathern and Heeger, 2015).  
Because the complement cascade has the ability to generate a massive amount of 
inflammation and cause significant tissue damage, it must be kept under strict control.  Activation 
can be controlled at different steps of the cascade and the importance of these regulators is 
demonstrated by cases in which deficiency results in disease (Walport, 2001a; b).  The complement 
cascade has both fluid-phase proteins and membrane bound regulators in place that participate in 
the clearance of complement-coated particles and protect host cells from damage (Meri and Jarva, 
2001).  The major fluid phase regulatory proteins include C1 inhibitor, C4 binding protein (C4BP), 
factor H (fH), clusterin and vitronectin (Figure 1.2) (Blom et al., 2009).  C1 inhibitor prevents 
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activation of C1 and subsequent cleavage of C4 and C2, while C4BP accelerates the decay of 
C4bC2b C3 convertase (Meri and Jarva, 2001; Blom et al., 2009).  Although these proteins act via 
different mechanisms, both inhibit activity of C3 convertase within the classical and lectin pathway 
therefore limiting activation.  Factor H plays a similar role to C4BP by blocking the alternative 
pathway C3 convertase, however it can block C3 convertase activity via three different 
mechanisms.  fH functions by binding to C3b to inhibit Bb binding, accelerating the decay of 
C3bBb, and it acts as a cofactor to speed up cleavage of C3b to the inactive iC3b (Meri and Jarva, 
2001).  Both clusterin and vitronectin act on the terminal complement pathway by binding the 
C5b-C9 complex which prevents addition of C9 molecules and insertion into the target cell 
membrane.  The resulting protein complexes are soluble and unable to induce cell lysis (Meri and 
Jarva, 2001).  Membrane bound regulators of complement include complement receptor 1 (CR1, 
CD35), membrane cofactor protein (MCP, CD46), decay-accelerating factor (DAF, CD55) and 
protectin (CD59) (Meri and Jarva, 2001).  CR1, MCP and DAF inhibit C3 and C5 convertases and 
protectin acts in a manner similar to clusterin and vitronectin by inhibiting insertion of the MAC 
into the cell membrane (Meri and Jarva, 2001). These regulatory proteins are present are a variety 





Many human pathogens have evolved mechanisms to utilize these host regulatory proteins 
to their advantage, thereby protecting themselves from complement-mediated attack during the 
establishment of infection.  Both Gram-negative and Gram-positive bacteria such as Haemophilus 
influenzae, Moraxella catarrhalis and Streptococcus pyogenes can bind to one or more of the fluid-
phase regulators of complement via distinct proteins that are diverse in sequence, but share similar 
structural integrity (Singh et al., 2010b; Zipfel et al., 2013).  Group-A S. pyogenes for example, 
expresses an outer membrane protein termed M protein with an alpha-helical coiled coil structure. 
(Buffalo et al., 2016).   The extracellular portion of this protein is hyper variable and different 
splice variants are capable of binding several plasma proteins including C4BP and fH to evade 
Figure 1.2. Major fluid phase regulatory proteins of the complement cascade.  A. C4BP 
regulates formation of the classical and mannose-binding lectin C3 convertase B. FH controls 
alternative pathway C3 convertase formation and C. vitronectin regulates formation of the 
membrane attack complex (Singh et al., 2010b). 
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serum killing (Thern et al., 1995; Morfeldt et al., 2001).  Interestingly, binding C4BP has also been 
correlated with resistance to phagocytosis of the bacteria (Horstmann et al., 1988; Carlsson et al., 
2003).  Another pathogen capable of binding multiple complement regulatory proteins is Neisseria 
gonorrhoeae.  This bacterium abundantly expresses an outer membrane protein, Porin, that 
consists of a 16-stranded transmembrane β-barrel with 8 long surface exposed loops  (Massari et 
al., 2003; Stefanelli et al., 2016).  Porin has been demonstrated to be essential for bacterial survival 
and can bind both C4BP and fH providing the bacteria resistance to all arms of complement 
mediated attack (Ram et al., 1998; Ram et al., 2001).  Furthermore, some human pathogenic yeasts 
including Aspergillus species and Candida albicans have also evolved mechanisms to bind 
complement regulatory proteins thus promoting fungal pathogenesis (Vogl et al., 2008; Lesiak-
Markowicz et al., 2011). Clearly, binding plasma proteins is an important mechanism that many 
different pathogens have evolved to conquer the innate immune defense system of complement, 
and hence increase survival and pathogenicity.   
1.3 Rickettsia and Complement 
In the process of testing a preventative vaccine, Chan et al (2001) discovered that R. conorii 
are inherently resistant to complement mediated killing in the absence of neutralizing antibodies.  
This lead to the discovery of two separate mechanisms by which rickettsia imitate the natural 
protected state of host cells where complement is inherently blocked.  The first mechanism of 
resistance identified was by way of factor H binding to the surface of R. conorii (Riley et al., 2012).  
When R. conorii was incubated with human serum, Riley et al. (2012) demonstrated a salt-sensitive 
interaction between fH and the bacterial surface.  This interaction inhibited C3 and MAC 
deposition on the outer membrane and subsequently prevented serum killing (Riley et al., 2012).  
The rickettsial protein involved in this beneficial protein-protein interaction was identified through 
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anti-fH immunoprecipitation as the beta-peptide of outer-membrane protein B (OmpB).  
Additionally, when R. conorii was incubated with fH depleted serum, a reduction in serum survival 
was observed; however, this treatment did not result in the complete clearance of R. conorii in 
vitro suggesting that, although the fH-OmpB interactions play an important role in the inhibition 
of complement-mediated killing, other mechanisms contribute to the overall serum resistant 
phenotype (Riley et al., 2012). .  
During this time, the Martinez lab was also examining a protein encoded by the R. conorii 
open reading frame which had been previously identified to interact with an unknown mammalian 
protein and subsequently termed Adr1 (Renesto et al., 2006). Interestingly, the structure of this 
protein was related to a family of proteins exemplified by E. coli OmpX (Figure 1.3) (Riley et al., 
2014).  Members of this protein family have been documented to acquire host complement 
regulatory proteins including Yersinia enterocoliticia Ail and Salmonella typhimurium Rck (Bartra 
et al., 2008; Ho et al., 2010).  Because of the structural similarities, R. conorii Adr1 was predicted 
to be a surface exposed protein that could potentially sequester serum proteins (Riley et al., 2014).  
Initially, Adr1 expression was verified at the surface of R. conorii through flow cytometry utilizing 
an antibody derived against the predicted extracellular domains of the protein.  Upon verification 
of surface expression, Adr1 was recombinantly expressed on the surface of a serum-sensitive strain 
of E. coli and exposed to human serum. Expression of Adr1 on the surface of the E. coli was 
sufficient to confer serum resistance (Riley et al., 2014).  The data suggests that Adr1 is involved 





Because depletion of fH from human serum resulted in a partial increase in serum 
sensitivity, it was hypothesized that R. conorii is able to sequester other complement regulatory 
proteins.  To test this theory, the bacteria were incubated with human serum and probed for co-
sedimentation with C1 esterase, C4BP, clusterin and vitronectin (unpublished data from the 
Martinez laboratory).   By western immunoblot analysis, vitronectin was demonstrated to interact 
with R. conorii while C1 esterase, C4BP and clusterin did not (unpublished data from the Martinez 
laboratory).  Deposition of vitronectin on the surface of the bacteria was also confirmed by flow 
cytometric analysis utilizing an anti-vitronectin antibody (Riley et al., 2014). To examine the 
importance of Adr1-vitronectin interactions, Adr1 was again expressed in a serum-sensitive strain 
Figure 1.3. Models of the predicted structure of outer-membrane proteins OmpX and Adr1.   
Pictured here is the predicted structure of E. coli OmpX and R. conorii Adr1.  Both proteins 
are predicted to consist of 8 transmembrane beta-sheets that form a pore-like structure, 4 
periplasmic loops and 4 extracellular peptide loops.  Although diverse in sequence, the 
structural nature of this family of proteins is highly conserved.  This image is adapted from 
(Vogt and Schulz, 1999) and (Riley et al., 2014). 
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of E. coli, the bacteria were exposed to NHS and binding of vitronectin was evaluated.  Western 
immunoblot and flow cytometric analysis revealed that Adr1 expressing E. coli bound significantly 
more vitronectin then E. coli expressing an empty vector (Riley et al., 2014).  These findings allude 
to a correlation between vitronectin acquisition by Adr1 and serum resistance.  
 A paralog to R. conorii Adr1, Adr2, has also been identified as a vitronectin binding protein 
(Garza et al., 2017).  Adr2 is a conserved outer-membrane protein that has been identified in all 
pathogenic rickettsial species to date and has been implicated in the entry of R. prowazekii into 
non-phagocytic mammalian cells (Gong et al., 2014a; b). In R. conorii, Adr2 has been implicated 
in mediating serum resistance.  When the protein was expressed on the surface of a serum sensitive 
strain of E. coli and exposed to human serum, expression of Adr2 was sufficient to mediate serum 
resistance when compared to E. coli expressing an empty vector (Garza et al., 2017). Furthermore, 
Garza et al (2017) demonstrated that Adr2 binds vitronectin via flow cytometry.  Although the 
group did not demonstrate a role for Adr2 in bacterial adherence to mammalian cells, they 
discovered a redundant mechanism by which R. conorii binds vitronectin to the bacterial cell 
surface.  Taken together the data suggests that binding of fH and vitronectin by R. conorii and 
other rickettsial species including R. rickettsii, plays an important role in evasion of the 
complement cascade and that rickettsial species have evolved multiple mechanisms to evade serum 
killing while in hematogenous circulation.   
1.4 Vitronectin 
The open reading frame of vitronectin encodes for 459 amino acids preceded by a 19 amino 
acid signal sequence (Schvartz et al., 1999).   The protein has a predicted molecular mass of 75kD 
and can be found in circulation as a single chain (75kD) or as two chains linked by a disulfide 
bond (65kD and 10kD).  Post-translational modifications such as sulfatation and phosphorylation 
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make up about 30% of the total mass; however, no functional significance has been attributed to 
these modifications to date (Preissner and Seiffert, 1998).  The protein consists of various 
functional domains some of which have specific roles in biological processes while others remain 
undefined (Figure 1.4).  The N-terminal portion consists of a somatomedin-B (SMB) domain that 
is involved in the binding of plasminogen activator inhibitor-1 (Schvartz et al., 1999). Immediately 
following the SMB domain is a cell receptor binding site characterized by an arginine-glycine-
aspartic acid (RGD) sequence.  This domain mediates attachment of cells to the extracellular 
matrix though specific integrin receptors (Schvartz et al., 1999; Lossner et al., 2009).  The protein 
also contains 4 hemopexin-like domains that are putative heme-binding motifs although a specific 
function is still unclear (Singh et al., 2010b).  Additionally, vitronectin has three heparin binding 
domains spanning resides 82-137, 175-219 and 448-361 and a C-terminal region with an unknown 
function (Liang et al., 1997b).  Interestingly, many bacterial pathogens have evolved mechanisms 
to sequester vitronectin and the majority bind within this C-terminal region (Hallstrom et al., 
2016).  
Figure 1.4. Schematic representation of the various domains found in vitronectin.  Pictured 
here are the various functional domains of vitronectin.  The N-terminal somatomedian domain 
depicted in tan binds plasminogen activator inhibitor-1 which is followed by the RGD domain 
that interacts with cellular integrin receptors.  The 4 hemopexin domains that are predicted 
heme binding motifs are shown in purple. The 3 heparin binding domains are represented here 




Vitronectin was first identified in 1967 as an inhibitor of the membrane attack complex 
and subsequently named S-protein for serum spreading factor protein, but was later renamed due 
to its adhesive properties (Hayman et al., 1983; Schvartz et al., 1999).  It is a multifunctional 
human glycoprotein that is synthesized in the liver and secreted into the plasma (Preissner and 
Seiffert, 1998).  This protein is an important part of the extracellular matrix and as such plays a 
critical role in many biological processes including cell migration, tissue repair, adhesion, 
angiogenesis and regulation of membrane attack complex formation (Preissner and Seiffert, 1998; 
Singh et al., 2010b).  It is found at a high concentration in plasma (between 200 to 700 μg/ml) and 
within many human tissues.  Concentrations are particularly high in the liver, tonsils, heart, skeletal 
muscle, duodenum and lungs (Singh et al., 2010b).  Additionally, vitronectin is found at high 
concentrations in some malignant carcinomas suggesting that it may play a role in tumor 
development (Berglund et al., 2008). The protein exists in both a monomeric and multimeric form.  
Most of the circulating protein in the blood exists as a monomer while extravascular vitronectin is 
usually found in a cell bound multimeric form (Peterson, 1998). 
Vitronectin-mediated serum resistance is well-documented for many bacterial pathogens.  
Both Gram-negative and Gram-positive pathogens including Helicobacter pylori, Moraxella 
catarrhalis, Neisseria meningitidis, Streptococcus pneumoniae, Yersinia pestis and Pseudomonas 
aeruginosa can obtain vitronectin by one or more outer membrane proteins to evade complement-
mediated killing (Sa et al., 2010; Singh et al., 2010a; Griffiths et al., 2011; Bartra et al., 2015; 
Hallstrom et al., 2015; Kohler et al., 2015; Richter et al., 2016).  For example, both non-typeable 
and typeable strains of the respiratory pathogen Haemophilus influenzae, can acquire vitronectin 
by several different proteins: Protein E, Protein F, Protein H and Haemophilus surface fibrils (Hsf) 
(Hallstrom et al., 2006; Hallstrom et al., 2009; Singh et al., 2011; Su et al., 2013; Al-Jubair et al., 
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2015) This redundancy ensures vitronectin acquisition and protection from the MAC.  The 
urogenital pathogen, Haemophilus ducreyi, an outer-membrane protein termed ducreyi serum 
resistance protein (DsrA), was demonstrated to bind to vitronectin (Elkins et al., 2000).  When H. 
ducreyi DsrA knockout mutants were utilized to infect human volunteers, the patients did not 
develop an infection.  This suggests that vitronectin mediated serum resistance contributes to the 
infectivity of this bacteria (Bong et al., 2001) 
Bacteria can also sequester vitronectin to facilitate adherence to and invasion of target host 
cells.  Distinct binding sites for bacteria and integrins exist within the functional domains of 
vitronectin and as such bacteria can utilize this to their advantage (Singh et al., 2010b).  The 
respiratory pathogen, S. pneumonia, preferentially binds multimeric vitronectin to enhance 
adherence to respiratory epithelial cells. The bacteria could also bind monomeric vitronectin, but 
to a lesser extent indicating that cell-bound vitronectin was the preferable target for adhesion 
(Bergmann et al., 2009).  Binding of vitronectin by Pseudomonas aeruginosa increases adherence 
and internalization into A549 alveolar epithelial cells. When antibodies against vitronectin and 
αvβ5 were utilized, bacterial binding and invasion was significantly decreased demonstrating a 
direct role for a vitronectin mediated adherence and invasion (Chhatwal et al., 1987; Leroy-Dudal 
et al., 2004).  Vitronectin mediated adherence has also been demonstrated for other pathogens, 
such as Streptococcus pyogenes, Enterococcus faecalis, Neisseria meningitidis and the dental 
bacteria, Porphyromonas gingivalis; however, whether or not this interaction also plays a role in 
mediated serum resistance remains to be elucidated (Liang et al., 1997a; Olczak et al., 2001; Tyriak 
and Ljungh, 2003; Sa et al., 2010; Singh et al., 2010b).  
Vitronectin acquisition is an advantageous characteristic shared by many human bacterial 
pathogens.  These bacteria have co-evolved mechanisms to sequester vitronectin to evade serum 
19 
 
killing and facilitate adherence to and invasion of host cells.  We have previously demonstrated 
that R. conorii expresses a conserved outer-membrane protein, Adr1, that binds to vitronectin to 
elude complement mediated killing. Therefore, we theorize that like other blood-borne bacterial 
pathogens, Rickettsia species can acquire vitronectin to evade complement mediated killing and to 
facilitate interactions with target host cells.  In this body of work, we will further explore this 
hypothesis by elucidating the biochemical characteristics of the R.conorii Adr1/vitronectin 
interaction and examining how acquisition of vitronectin contributes to the establishment of a 
successful infection. Understanding the molecular mechanisms by which pathogenic Rickettsia 
species establish infections in mammalian hosts will hopefully better guide us into developing 
novel therapeutics, vaccine candidates and a greater understanding of rickettsial pathogenesis.  
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THE RICKETTSIA CONORII ADR1 INTERACTS WITH THE  






Spotted Fever group (SFG) Rickettsia are Gram-negative, obligate intracellular bacteria 
that are transmitted to a mammalian host when an arthropod vector takes a blood meal (Riley et 
al., 2012). Members of the SFG include the human pathogens R. conorii and R. rickettsii, the 
etiologic agents of Mediterranean Spotted Fever and Rocky Mountain Spotted Fever, respectively.  
Upon inoculation into a host, the bacteria can spread throughout the body via the bloodstream and 
parasitize cells of many origins, including endothelial cells, monocytes, macrophages and 
hepatocytes (Walker and Gear, 1985; Feng et al., 1994; Walker, 1997; Walker et al., 1999; Riley 
et al., 2016). Infection of endothelial cells can lead to disruption of the endothelial lining and 
increased fluid leakage which causes the characteristic macropapular rash, thus the name Spotted 
Fever (Walker and Ismail, 2008).  If left untreated, infections can lead to severe manifestations of 
the disease such as renal failure, non-cardiogenic pulmonary edema, interstitial pneumonia and 
ultimately death (Walker and Ismail, 2008). When rickettsial infection is properly diagnosed, 
treatment is generally successful; however, misdiagnosis is common due to initial non-descript 
flu-like symptoms, which leads to increased morbidity and mortality (Chan et al., 2009; Riley et 
al., 2014).  
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Because of the obligate intracellular nature of SFG Rickettsia, the bacteria must bind to 
and invade a host cell in order to survive and proliferate (Walker and Ismail, 2008).  However, 
 during arthropod feeding and rickettsia dissemination, the bacteria are extracellular and as a result 
are exposed to the hostile environment of the mammalian bloodstream (Riley et al., 2014).  While 
outside the safety of the host cell cytosol, the bacteria are exposed to the bactericidal effects of the 
host’s complement system and survival of these bacteria are dependent upon their ability to evade 
killing until a proper cellular host is reached (Riley et al., 2012). 
The complement system contributes to both the innate and adaptive immune system and 
serves as the first line of defense against invading organisms. Complement is composed of fluid-
phase and membrane bound proteins that can be activated through three different mechanisms 
(Singh et al., 2010a). The classical, the lectin and the alternative pathways are initiated by 
antibodies or various proteins that recognize structures on the surface of a microbe and the 
pathways converge at the formation of C3 convertase to form the common lytic pathway (Blom et 
al., 2009).  This results in the deposition of membrane attack complex (MAC) proteins C5b through 
C9 on the surface of the pathogen and accumulation of these proteins leads to formation of a lytic 
pore in the membrane which causes osmotic cell lysis (Singh et al., 2010b).  Other functions of 
complement include increased opsonization of the pathogen by binding of C3b components to the 
surface of the microbe and stimulation of inflammatory responses with the proteins C3a, and C5a 
(Blom et al., 2009).   
The complement cascade must be kept under strict control, bercause activation can result 
in significant inflammation and can attack both foreign molecules as well as a self components.  
As such, the host utilizes a series of regulatory proteins which include Factor I, Factor H, C4-
binding protein, vitronectin and clusterin (Singh et al., 2010b).  These proteins associate with the 
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surface of host cells in order to control and block complement activation (Hallstrom et al., 2015). 
Many bacterial pathogens, including Moraxella catarrhalis, Neisseria meningitidis, Streptococcus 
pyogenes, S. pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa have evolved 
mechanisms to utilize these host regulatory proteins to their advantage, thereby protecting 
themselves from complement-mediated attacks (Liang et al., 1997; Singh et al., 2010a; Griffiths 
et al., 2011; Voss et al., 2013; Riley et al., 2014; Hallstrom et al., 2015).  
A previous report demonstrated that R. conorii is inherently resistant to complement-
mediated killing when exposed to human serum (Chan et al., 2011). This information led to the 
discovery of a protein that is expressed on the surface of R. conorii, termed Adr1, that contributes 
to the serum resistance phenotype by binding the multifunctional human glycoprotein vitronectin 
(Riley et al., 2014).  Vitronectin binds to complement proteins C5b-C7 and C9 to inhibit deposition 
of the MAC on the bacterial surface (Singh et al., 2011).  The R. conorii vitronectin-binding 
protein, Adr1, is a conserved outer membrane protein that is predicted to contain 8 trans-membrane 
beta sheets that form a membrane spanning barrel, as well as four connecting beta strands termed 
“loops” that protrude into the extracellular environment (Vogt and Schulz, 1999; Riley et al., 
2014). Our lab previously demonstrated that two of these domains, loops 3 and 4, were sufficient 
to interact with vitronectin and thus, mediate resistance to serum killing when Adr1 proteins 
containing either loop 3 or loop 4 were expressed in a serum-sensitive strain of E. coli (Riley et 
al., 2014). Interestingly, homologs of Adr1 are present in every sequenced rickettsial species to 
date and the deduced amino acid sequences of loop 3 and loop 4 are almost 100% conserved among 
spotted fever group rickettsial species (Riley et al., 2014), suggesting that resistance to serum 
mediated killing mediated by Adr1 may be a widespread virulence attribute in this class of obligate 
intracellular pathogens.  
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In the present study, we further analyzed the interaction between Adr1 and vitronectin with 
the intention of understanding in detail the mechanisms of interaction.  We demonstrated that the 
interaction of Adr1 with vitronectin is sensitive to increasing salt concentrations, and not 
competitively inhibited by increasing concentrations of heparin. Using various truncated, 
recombinant vitronectin peptides, we also demonstrate that the Adr1-vitronectin interaction maps 
to a region located in the C-terminal domain of vitronectin.  Furthermore, we utilized site-directed 
mutagenesis to determine the specific amino acids located within loop 3 and 4 of Adr1 that are 
critical in mediating resistance to complement-mediated killing in serum. 
2.2 Materials and Methods 
2.2.1 Construction of Mutants in Adr1 by PCR 
Plasmids pJP01-L3 and pJP01-L4 as previously described (Riley et al., 2014) were utilized 
as a template for quick-change site-directed mutagenesis PCR to mutate individual lysine residues 
in each loop to alanine residues.  Briefly, plasmids pJP01-L3 and pJP01-L4 contain the gene for 
an Adr1 derivative with only intact loop 3 or loop 4, respectively.  All other loops have been 
reduced to the bare minimum amino acids necessary to maintain structural integrity of the protein 
(Riley et al., 2014). Primers for mutations can be found in appendix A located at the end of chapter 
4.  In each case, parental DNA was digested using DpnI leaving mutant plasmid, which was then 
transformed into MaxEfficiency DH5-alpha-T1 (Life Technologies) and sequenced. Mutants were 
constructed for single amino acid substitutions as well as multiple and multiple, sequential amino 
acid substitutions for all 6 lysine residues in pJP01-L3 and pJP01-L4.  
2.2.2 Bacterial Strains and Culture Conditions 
E. coli BL21 (DE3) (pJP01, pJP01-L3, pJP01-L4, pET22b, pJP01-L3 mutants and pJP01-
L4 mutants) were cultured in Luria-Bertani (LB) broth at 37°C with 50 μg/mL of carbenicillin 
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overnight.  Bacteria were then diluted 1:10 into fresh media and grown to an OD600 between 0.5 
and 1.0. Protein expression was induced with 0.6 mM IPTG (Isopropyl β-D-1-
thiogalactopyranoside) and cultures were grown for 4 h at 37°C. 
2.2.3 Antibodies 
Rabbit Anti-Adr1 peptide polyclonal antibodies (pAb) were utilized for immunoblot 
analysis of Adr1-expressing E. coli as previously described (Riley et al., 2014).  Anti-E. coli RNA 
polymerase monoclonal IgG3 antibody (Ab) was purchased from Affinity Bioreagents. Rabbit IgG 
anti-human vitronectin pAb was purchased from Complement Technology and sheep anti-human 
vitronectin IgG was from AbD Serotec.  Mouse IgG anti-Histidine tag pAb directly conjugated to 
horseradish peroxidase (HRP) was purchased from GenScript. Both donkey anti-mouse IRDye 
680 IgG and donkey anti-rabbit IRDye 800 IgG were purchased from LiCOR biosciences. HRP-
conjugated goat anti-rabbit IgG was from Sigma and donkey anti-sheep IgG was purchased from 
Thermo-Fisher.   
2.2.4 Vitronectin Binding Assay 
To evaluate vitronectin binding, E. coli BL21 (DE3) containing plasmids pJP01, pET22b, 
or mutants were grown as described previously.  Approximately 1x106 colony forming units (cfu) 
of each construct was washed with PBS and resuspended in 200μL PBS containing 25% normal 
human serum (NHS) pooled from 5 healthy individuals (Innovative Research).  For analysis of 
vitronectin binding in the presence of NaCl or heparin, NaCl was purchased from Fisher Chemical 
and Heparin Sodium Salt was purchased from MP Biomedicals, LLC.  The Adr1 and mutant 
expressing bacteria were resuspended in 100μL PBS containing increasing concentrations of either 
NaCl (0M, 0.25M, 0.50 M or 1.0M) or heparin (0nM, 1nM, 2nM, 4nM, 8nM, 12nM, 16nM, 20nM, 
or 500nM).  100μL of 50% NHS was then added to the heparin/E.coli or NaCl/E.coli solution for 
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final NHS concentration of 25%.  For analysis of binding of vitronectin peptides, 1x106 cfu Adr1 
expressing E. coli were resuspended in a 100μL of a 5μM solution of each indicated purified 
recombinant peptide that had been expressed and isolated from HEK293T cells (Singh et al., 
2010a).  For analysis of vitronectin binding to R. conorii, a live, frozen stock of R. conorii was 
allowed to come to room temperature and resuspended in 50μL of a heparin or salt solution at 
concentrations previously mentioned and 50μL of 50% NHS was added for a final NHS 
concentration of 25%. To assess differences in multimeric and monomeric vitronectin binding to 
mutant expressing E. coli, multimeric and monomeric vitronectin were purchased from Innovative 
Research. Roughly 1x106 cfu of Adr1 and mutant expressing bacteria were washed and 
resuspended in 25μL of PBS. 25μL of 50ng/mL of monomeric or multimeric vitronectin was then 
added for a final concentration of 25ng/mL vitronectin. Adr1 expressing E. coli were incubated on 
ice when bacteria were resuspended in NHS whereas bacteria resuspended in monomeric, 
multimeric or recombinant peptide vitronectin were incubated at room temperature.  R. conorii 
were also incubated at room temperature.  All samples were allowed to bind for 1 h with gentle 
agitation, bacteria were washed 3 times in PBS and vitronectin binding was determined by SDS-
PAGE and western immunoblotting using rabbit anti-human vitronectin or sheep anti-human 
vitronectin as primary antibody and goat anti-rabbit IgG HRP or donkey anti-sheep IgG HRP as 
secondary antibody. 
2.2.5 Serum Resistance Assay 
Normal human serum pooled from 5 healthy individuals (NHS) (Innovative Research) was 
stored at -80°C as aliquots until use.  E. coli BL21 (DE3) containing pJP01-L3, pJP01-L4, pET22b 
or loop 3 and loop 4 mutants were grown as described above.  Approximately 1 x 106 bacteria 
were then washed with PBS and resuspended in either 200 μL of PBS or 200 μL PBS containing 
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10% NHS. Bacteria were incubated at 37°C for 15 min with agitation and then serially diluted in 
PBS and plated on LB-Agar plates.  After overnight incubation, colony-forming units (cfu) were 
evaluated.  Experiments were performed in triplicate with a minimum of 3 replicates for each 
experiment. Data is presented as the cfu of bacteria in PBS/cfu of bacteria in 10% NHS after 15 
min of incubation and plotted on a logarithmic scale.  Expression of Adr1or Adr1 mutant proteins 
was verified by western immunoblotting using rabbit anti-Adr1 or mouse anti-histidine tag 
antibodies as described above.  
2.2.6 Bacterial Fractionation 
Induced E. coli BL21 (DE3) cultures (250 mL) were pelleted, resuspended in 5 mL PBS 
containing 1x protease inhibitor cocktail and then fractionated to enrich for outer-membrane 
proteins as described (Hancock and Nikaido, 1978).  Briefly, bacteria were twice lysed in a French 
Pressure cell (1,500 psi) and unbroken cells were cleared by centrifugation at 3,000 g for 15 min 
at 4°C.  Sarkosyl was added to the resulting supernatant (total cell lysate) to a final concentration 
of 0.5% and incubated with rotation at room temperature for 10 min to extract inner membrane 
proteins.  Outer membrane proteins were pelleted by ultracentrifugation for 1 h at 100,000 g and 
resuspended in 2x sample buffer.  Total cell lysate, inner membrane fraction and outer membrane 
fraction were resolved by SDS-PAGE and stained with Coomassie blue for visualization of total 
protein content and analyzed by western immunoblotting with anti-Adr1 antibodies. 
2.2.7 Statistical Analysis 
Statistical Analysis was performed using a one-way ANOVA with a Neuman-Keuls post 
hoc test or a Kruskal-Walis one-way ANOVA test to compare differences between more than two 
groups as indicated.  Differences were considered significant with a p-value less than or equal to 
0.05 using Graph-Pad Prism version 5.0b (GraphPad Software). 
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2.3 Results 
2.3.1 Vitronectin binding is significantly reduced by increasing concentrations of NaCl, but is not 
substantially inhibited by heparin 
 
Vitronectin contains many different functional regions that mediate its various roles in the 
human host (Singh et al., 2010a). Heparin-binding domains have been demonstrated to be involved 
in the interaction between vitronectin and Outer-membrane protein C (Opc) of N. meningitis, 
Ubiquitous surface protein A2 (UspA2) of M. catarrhalis, Lpd of P. aeruginosa and several other 
pathogenic bacteria (Sa et al., 2010; Griffiths et al., 2011; Hallstrom et al., 2015).  The charge of 
the individual amino acid residues within the binding domains of the outer membrane proteins of 
S. pneumoniae and Haemophilus influenzae have also been documented to play a role in binding 
(Hallstrom et al., 2009; Voss et al., 2013). Because of the high concentration of positively charged 
lysine residues located within loops 3 and 4 of Adr1, we hypothesized that these residues would 
play an important role in the protein-protein interaction. To determine if the R. conorii 
Adr1/human vitronectin interaction is a result of Adr1 interacting with the heparin binding 
domains or is an electrostatic interaction, Adr1 was expressed at the surface of E. coli and exposed 
to human serum in the presence of either increasing concentrations of heparin or NaCl.  As the 
concentration of heparin in soluation was increased 0 nM to 500 nM, which is approximately 3 
times the concentration found in human plasma (Engelberg, 1961), there was no significant 
difference in ability of vitronectin to bind to Adr1 (Figure 2.1A). In contrast, increasing 
concentrations of NaCl in solution ranging from 0 M to 1 M in the reaction, competitively inhibited 
the interaction between vitronectin and Adr1 (Figure 2.1B).  Interestingly, when increasing 
concentrations of both NaCl or heparin were added to intact R. conorii cells in the presence of 
NHS, there was no significant difference in the ability of vitronectin to bind to R. conorii (Figures 
2.1 C and 2.1D).   These data suggest that R. conorii and other pathogenic rickettsial species may 
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possess additional factors that are sufficient to interact with vitronectin and may contribute to this 
phenotype.  Nevertheless, this data suggests that the heparin-binding domains of vitronectin are 
not involved in the Adr1/vitronectin interaction, and that specific charged amino acid residues in 





Figure 2.1. Vitronectin binding to E. coli expressing Adr1 or R. conorii. A & B. Western 
immunoblot analysis of vitronectin binding to E. coli expressing Adr1 in the presence of 
increasing concentrations of heparin (0nM to 500nM) or NaCl (0M to 1M). Equal loading in 
each experiment was verified using an E. coli RNA polymerase antibody.  Verification of Adr1 
expression was validated using anti-Adr1.  Data are representative of at least 3 independent 
experiments. C & D. Western immunoblot analysis of vitronectin binding to R. conorii in the 
presence of increasing concentrations of heparin or NaCl.  Equal loading in each experiment 
was verified using anti-OmpB and anti-Adr1 antibodies. Data are representative of 2 replicates. 
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2.3.2 Adr1 binds within the C-terminal region of vitronectin between amino acids 363 and 373 
We next wanted to identify the region(s) within vitronectin that mediate binding to Adr1. 
The C-terminal region (amino acids 312-396 depicted in Figure 2.2A) of vitronectin is well 
documented to mediate binding of serum resistance proteins from bacterial pathogens such as 
Protein E from H. influenzae, UspA2 from M. catarrhalis, and the PspC protein from S. 
pneumoniae (Singh et al., 2010a; Griffiths et al., 2011; Singh et al., 2011; Voss et al., 2013; 
Hallstrom et al., 2016).  Because this region plays an important role in many interactions of both 
Gram-negative and Gram-positive bacteria, we hypothesized that Adr1 would also bind within the 
C-terminal region.  To test this hypothesis, we performed vitronectin binding assays using a series 
of recombinant, truncated vitronectin peptides demonstrated in a silver stain in Figure 2.2B. (Singh 
et al., 2010a; Su et al., 2013)) and Adr1-expressing E. coli BL21(DE3).  As shown in Figure 2.2C, 
peptides Vn 80-396, Vn 80-379, Vn 80-373 and Vn Δ352-362 were sufficient to bind to Adr1 
expressed at the outer membrane of E. coli.  Our data demonstrates that the region between amino 
acid 363 and 373 within the C-terminal region of vitronectin is involved in the binding of Adr1 
and further demonstrate that Adr1-vitronectin interactions do not require heparin-binding domains.  
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2.3.3 Serum survival of E. coli expressing Adr1 lysine to alanine mutants 
We have previously demonstrated that extracellular Adr1 loops 3 and 4 are sufficient to 
both mediate resistance to complement-mediated killing and bind vitronectin (Riley et al., 2014).  
Figure 2.2. Functional domains in vitronectin and peptides constructed for analysis of Adr1 
binding region. A. Full length vitronectin with noted functional domains is depicted in the top 
black arrow with the constructed peptides depicted in gray arrows below. B. Silverstain of 
vitronectin peptides utilized. The first 8 peptides begin at amino acid 80 and are progressively 
truncated at the C-terminus.  The 3 full length peptides contain a deletion within the C-terminal 
region. C. E. coli expressing Adr1 binds to the 3 longest vitronectin peptides and the full-length 
peptide with a deletion at amino acids 352-362. Equal loading is demonstrated with anti-E. coli 
RNA polymerase and verification of expression of Adr1 is verified using anti-Adr1. Data are 
representative of at least 3 replicates.  
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We, therefore, sought to identify residues within each loop that were responsible for the 
interaction.  We utilized the previously constructed plasmids, pJP01-L3 and pJP01-L4 (Riley et 
al., 2014) which encode Adr1 proteins expressing only loops 3 or 4, respectively as templates for 
Site-directed mutagenesis to substitute positively charged lysine residues to uncharged, non-polar 




Figure 2.3. Schematic representation of K-A substitutions in R. conorii Adr1 loops 3 and 4. 
The position of each substituted lysine in loops 3 and 4 and the corresponding name of the 
plasmid is depicted above and verification of expression of Adr1 is verified using anti-Adr1. 
Data are representative of at least 3 replicates.  
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We initially verified expression of each construct by transforming a serum-sensitive strain 
of E. coli BL21 (DE3) with the indicated plasmid and inducing protein expression as described 
above.  Western immunoblotting with anti-Adr1 antibodies confirmed the expression of each 
construct (Figure 2.4 and 2.5).  Constructs pAF15, pAF16, pAF25, pAF28 and pAF29 did not 
express under any condition tested and were not further utilized.  Because our data demonstrated 
that Adr1-Vn interactions are electrostatic in nature and that the Vn-interacting domains of Adr1 
(loops 3 and 4) contain a high concentration of positively charged amino acids, we hypothesized 
that removal of one or more of the positive charge would decrease the ability of Adr1-expressing 
E. coli to survive when exposed to serum and to interact with Vn.  To initially determine serum 
survival, each Adr1 mutant was expressed in E. coli and incubated in 10% NHS in PBS and PBS 
alone as a control.  The colony forming units (CFU) of bacteria exposed to NHS were quantified 
in comparison to the bacteria exposed to PBS and bacterial survival was expressed as the percent 
bacteria remaining after exposure to serum.  As shown in Figure 2.6A and D, Adr1 mutants 
containing a single lysine to alanine substitution in any position within each loop remained 
resistant to serum killing.  In contrast, when the first two or more positive charges to uncharged 
substitutions were made, the ability of E. coli expressing Adr1 mutant proteins to resist serum 
killing was significantly decreased (Figure 2.6B, 2.6C, 2.6E and 2.6F).  These results suggest that 
the first two lysines in either loops 3 or 4 are critical to mediate resistance to serum mediated 
killing, but do not exclude the possibility that the net charge in either Adr1 loop contributes to the 
observed phenotype.  We, therefore, designed experiments to distinguish between these two 
possibilities.  Using the Adr1-loop 3 construct as a model, we created double lysine mutants at 
lysine positions 1 and 5 or at positions 5 and 6 (Figure 2.3), expressed these mutant Adr1 proteins 
in E. coli, and tested for their ability to survive in normal human serum.  As shown in Figure 2.7 
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E. coli expressing the indicated lysine to alanine substitutions in Adr1 were able to survive when 
exposed to human serum.  Taken together, these data demonstrate that the first two lysine residues 
loop 3 are critical to mediate resistance to complement mediated killing and suggests that these 
residues may play important roles in the interaction with vitronectin. 
 
Figure 2.4. Expression of Adr1 loop 3 mutants in E. coli BL21(DE3). Western immunoblot 
analysis of whole cell lysates for each mutant constructed within loop 3 using anti-Adr1. 
 
Figure 2.5. Expression of Adr1 loop 4 mutants in E. coli BL21(DE3). Western immunoblot 




Figure 2.6. Analysis of loop 3 and 4 mutant Adr1 serum resistance when expressed on the 
surface of E. coli and exposed to NHS. A & D. A single lysine to alanine substitution (AF2 and 
AF7). B & E. A double lysine to alanine substitution at positions 1 and 2 (AF13 and AF17). C 
& F. A triple amino acid substitution at positions 1, 2 and 3 (AF14 and AF24). Data are 
representative of at least 3 replicates. A one-way ANOVA with a Newman-Keuls post hoc test 
was performed. * represent a p≤0.05 and is considered significant. ns represents no 
significance.  
 
Figure 2.7. Analysis of double mutants of loop 3 Adr1 serum resistance when expressed on the 
surface of E. coli and exposed to NHS. A. A double lysine to alanine substitution at positions 
1 and 5 (AF53). B. A double lysine to alanine substitution at positions 5 and 6 (AF55). Data 
are representative of at least 3 replicates. A one-way ANOVA with a Newman-Keuls post hoc 




2.3.4 Binding of multimeric Vitronectin is correlated with survival of Adr1-expressing bacteria 
We next sought to verify that the serum-resistant phenotypes are correlated with the ability 
of Adr1 to bind vitronectin.  We hypothesized that E. coli expressing Adr1 mutants that survived 
serum killing were sufficient to bind vitronectin, while E. coli expressing Adr1 mutants that did 
not survive in serum were either unable to bind or are greatly impaired in their ability to bind 
vitronectin.  To test this hypothesis, we transformed E. coli BL21(DE3) with the constructs for 
serum resistant Adr1 loop 3 proteins harboring a single amino acid substitution construct, 
representing serum resistant phenotypes (pAF1 and pAF2), the double amino acid constructs at 
positions 1 and 5 (pAF53) and at position 5 and 6 (pAF55). Plasmids encoding for serum-sensitive 
phenotypes were also transformed and include double substitution at positions 1 and 2 construct 
(pAF13) and triple substitution at positions 1, 2, and 3 construct (pAF14), representing the serum 
sensitive phenotype.  Adr1 loop 4 mutant proteins containing a single amino acid substitution 
(pAF8, serum resistant) and the double and triple mutants (pAF17 and pAF26, serum-sensitive) 
were also expressed in E. coli.  We initially verified the expression of Adr1 mutants at the outer 
membrane of E. coli when expressed under these conditions (Figure 2.8).  These bacteria were 
incubated with NHS and analyzed for their abilities to interact with human Vn via a Western 
immunoblot analysis.  Surprisingly, E. coli expressing either serum-resistant or serum-sensitive 





Figure 2.9. Serum resistance or sensitivity does not correlate with the ability to bind vitronectin 
in serum.  A & B. Western immunoblot analysis of vitronectin in serum binding to E. coli 
expressing loop 3 or loop 4 Adr1 mutants with both serum resistant and serum-sensitive 
phenotypes. Equal loading was verified using anti-E. coli RNA polymerase and Adr1 
expression was verified using anti-Adr1. Data are representative of at least 3 replicates. Arrows 
depict Adr1 constructs that confer resistance to serum killing. 
 
Figure 2.8. Confirmation of expression of mutant Adr1 proteins at the outer-membrane of E. 
coli. Western immune blot analysis of whole cell lysates (WCL), sarkosyl soluble/inner 
membrane proteins (IM) and outer membrane fractions (OM).  An Adr1 derivative containing 
only loop 4 (JP01-L4) was used as a positive control and the empty vector (pET22b) was used 
as the negative control.  Representative constructs of serum resistant (AF8) and serum-sensitive 
(AF17) and phenotypes are presented.   
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Vitronectin within the blood exists in both a monomeric and multimeric form.  
Consequently, Vn interactions that are responsible for Adr1-mediated serum resistance may in part 
be dependent on the form with which Adr1 interacts.  Because the vitronectin multimer is the 
functionally active form we hypothesized that serum resistant mutants were able to bind to the 
multimeric form of Vn while serum-sensitive mutants were unable or significantly reduced in the 
ability to bind to the multimer.  We also hypothesized that all mutants representing both serum-
resistant and sensitive phenotypes would bind to the vitronectin monomer. To test our hypotheses, 
the aforementioned constructs were expressed at the outer membrane of E. coli.  The bacteria were 
then incubated with monomeric and multimeric vitronectin and analyzed for the ability to bind to 
each form.  The results of our experiment demonstrated that serum-resistant mutants bound to 
multimeric vitronectin (Figure 2.10A and 2.10C) whereas serum-sensitive mutants had a decreased 
ability to bind to the multimer.  Conversely, all mutant regardless of phenotype were able to 
sufficiently bind to monomeric vitronectin (Figure 2.10B and 2.10D). These data indicate that 
electrostatic Adr1-Vn interactions are important for serum resistance and specifically serum 






A previous report from this laboratory demonstrated that R. conorii binds vitronectin (Vn) 
to facilitate evasion of complement-mediated killing (Riley et al., 2014).  Additionally, Adr1 loops 
3 and 4 were sufficient to mediate the interaction with Vn.  In the present study, we focused on 
elucidating the molecular determinants of the Adr1/vitronectin protein/protein interaction.   
Human vitronectin is a multifunctional human glycoprotein that is part of both the extracellular 
matrix and found in plasma.  This protein plays a role in many biological functions including cell 
Figure 2.10. Analysis of monomeric and multimeric vitronectin binding to loop 3 and 4 
mutants. A & C. Western immunoblot analysis of multimeric vitronectin binding to E. coli 
expressing loop 3 or loop 4 Adr1 mutants with both serum resistant and serum-sensitive 
phenotypes. B & D. Western immunoblot analysis of monomeric vitronectin binding to E. coli 
expressing loop 3 or loop 4 Adr1 mutants with both serum resistant and serum-sensitive 
phenotypes. Equal loading was verified using anti-E. coli RNA polymerase and Adr1 
expression was verified using anti-Adr1. Data are representative of at least 3 replicates. Arrows 
depict Adr1 constructs that confer resistance to serum killing 
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migration, tissue repair, and regulation of membrane attack complex formation by binding C5b-
C7 complex and inhibition of C9 deposition on the surface of a cell or microbe (Singh et al., 2010b; 
da Silva et al., 2015).  Vitronectin has a multi-domain structural arrangement that consists of an 
N-terminal somatomedian B domain which binds plasminogen activator inhibitor-1 and an RGD 
(arginine, glycine and aspartic acid) domain that interacts with several integrins thereby aiding in 
attachment (Blom et al., 2009).  Vitronectin also contains three heparin-binding domains and a C-
terminal region with an unknown function, both of which have been shown to bind to surface 
proteins of bacterial pathogens (Blom et al., 2009; Singh et al., 2010a; Singh et al., 2011). 
Homologs to human vitronectin are found among many mammalian species including rabbits, 
mice, and cows.  Interestingly, when these mammalian vitronectin proteins are compared there are 
regions of variability in both the N- and C-termini. Human vitronectin contains several unique 
residues within the C-terminal region, which may play an important role in protein-protein 
interactions (Leduc et al., 2009; da Silva et al., 2015).  Because vitronectin is one of the major 
regulators of membrane attack complex formation, it plays a critical role in deposition of the MAC 
on bacterial pathogens. Gram-negative pathogens including R. conorii, Legionella pneumophila, 
Neisseria meningitidis, Pseudomonas aeruginosa, M. caterrhalis, and H. influenzae utilize 
vitronectin to protect against MAC killing (Hallstrom et al., 2006; Hallstrom et al., 2009; Singh et 
al., 2010a; Riley et al., 2014; Hallstrom et al., 2016).  On the other hand, Gram-positive bacteria 
such as S. pneumoniae and S. pyogenes utilize vitronectin as a bridge to bind to and invade host 
cells (Leroy-Dudal et al., 2004; Singh et al., 2010b). 
Our results indicate that the Adr1/Vn interaction is a heparin-independent, electrostatic 
interaction based on the ability of increasing concentrations of NaCl, but not heparin to inhibit the 
interaction between the two proteins.  The ability of the recombinant peptide that contains a 
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deletion within the C-terminal heparin binding domain (352-362) to bind to Adr1 when expression 
on the surface of E. coli further supports our conclusion that the Adr1/Vn interaction is heparin-
independent.  To our knowledge, this is the first demonstration of an outer-membrane protein in a 
Gram-negative bacterial pathogen that interacts with vitronectin in a heparin-independent, salt-
sensitive manner.  Heparin-dependent interactions, on the other hand, are well documented in 
Gram-negative pathogens (Hallstrom et al., 2016) and include proteins such as Ubiquitous surface 
protein A2 (UspA2) of M. catarrhalis, Haemophilus surface fibrils (Hsf) of H. influenzae type B, 
and Protein E (PE) and Protein F (PF) from non-typable H. influenzae (NTHi) (Hallstrom et al., 
2006; Singh et al., 2010a; Singh et al., 2011; Su et al., 2013).  Interestingly, a Gram-negative 
pathogen, N. meningitidis, interacts with vitronectin via Meningococcal surface fibrils (Msf) in a 
heparin-independent manner; however, salt dependence has yet to be determined (Griffiths et al., 
2011).  Similarly, to the Adr1/vitronectin interaction in R. conorii, the Gram-positive pathogen, S. 
pneumoniae interacts with vitronectin via Pneumococcal surface protein C (PspC) in a salt 
sensitive manner, signifying an electrostatic interaction. Increasing concentrations of salt 
competitively inhibited the ability of vitronectin to bind to PspC suggesting that the negatively 
charged amino acids in PspC mediate this interaction; however, individual amino acids responsible 
for this interaction have yet to be identified (Voss et al., 2013). The Adr1/Vn interaction is different 
from other bacterial/Vn interactions and is likely unique to the Rickettsiales. 
We utilized recombinant vitronectin peptides to elucidate the Vn region(s) required for 
association with Adr1.  This region (amino acids 312-396) plays an important role in binding 
surface exposed proteins of both Gram-negative and Gram-positive bacterial pathogens (Singh et 
al., 2010a; Singh et al., 2011; Su et al., 2013; Voss et al., 2013; Hallstrom et al., 2016).  Like many 
other bacterial pathogens, Adr1 from R. conorii was demonstrated to bind within the C-terminal 
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region of vitronectin (amino acids 363-373), adjacent to the third heparin-binding domain.  In 
contrast, many gram-negative and gram-positive bacteria including S. pneumoniae, H. influenzae 
P. aeruginosa, Staphylococcus aureus, S. pyogenes all of which have heparin-dependent 
interactions with vitronectin, bind within a domain (amino acids 352 and 374) containing a portion 
of the third heparin-binding domain (Hallstrom et al., 2006; Singh et al., 2011; Voss et al., 2013; 
Hallstrom et al., 2016).  H. influenzae also utilizes a heparin-mediated interaction with vitronectin, 
but the region required for binding to PE encompasses a longer sequence (amino acids 353-396) 
(Hallstrom et al., 2009; Hallstrom et al., 2016).  
A few other electrostatic protein-vitronectin interactions have been described.  For 
example, the Gram-positive pathogen, S. pneumoniae utilizes PspC to bind vitronectin in a salt-
sensitive manner.  Although individual amino acids responsible were not identified, researchers 
suspect the negatively charged amino acids of the R domain in PspC mediate this interaction (Voss 
et al., 2013).  In addition, the Gram-negative pathogen, H. influenzae binds vitronectin via PE in a 
heparin-dependent manner; however, two amino acids, leucine 85 and arginine 86 have been 
identified as critical for this interaction (Singh et al., 2011).  Although leucine is an uncharged 
non-polar residue, arginine is positively charged and this charge could possibly contribute to the 
interaction.  We determined that the Adr1/vitronectin interaction was an electrostatic interaction 
that was not mediated by a single charged residue. Instead, we observed that a substitution in the 
first two lysine residues in loop 3 and 4 caused a significant decrease the inability of E. coli 
expressing these proteins to evade the bactericidal effects of normal human serum.  It is possible 
that these 2 amino acids in each loop independently create a critical initial interaction domain that 
is necessary for stable Adr1-vitronectin interactions and that without these two residues, Adr1 is 
not able to effectively mediate this protein-protein interaction.  This hypothesis is further supported 
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by the observation that perturbing the overall charge in Adr1 loop 3 had no deleterious effect on 
the ability of E. coli expressing this protein to survive serum-mediate killing.  
Surprisingly, our results did not demonstrate a direct correlation between the ability to bind 
Vn and the ability to mediate survival in serum.  Within human serum, vitronectin exists in both a 
monomeric and a multimeric form.  The predominant form in plasma is a monomer and is also 
referred to as the “native” form (Stockmann et al., 1993). Multimeric vitronectin is found in small 
quantities, and consists of intra-molecular interactions between monomers (Stockmann et al., 
1993). Previous studies examining vitronectin binding to outer-membrane proteins of various other 
pathogenic bacteria have looked at the native versus active form. The native form of vitronectin is 
folded, whereas the active form is conformationally altered and has an “open” structure, meaning 
that certain cryptic epitopes are available that are likely masked in the native form (Sa et al., 2010). 
Human serum is predicted to contain more than 7% of the activated form of vitronectin (Sa et al., 
2010).  Interestingly, the outer membrane protein, Opc of N. meningitidis exhibits preferential 
binding to the active form of vitronectin to mediate adhesion and invasion of brain cells (Sa et al., 
2010).  Conversely, Yersinia pestis utilizes two outer membrane proteins, Ail and Pla, to bind and 
proteolytically process the native form of vitronectin to facilitate resistance to complement 
mediated killing (Bartra et al., 2015). Upon further testing, we were demonstrated that serum-
resistant Adr1 mutants bound both multimeric and monomeric Vn whereas serum-sensitive 
mutants bound to monomeric Vn, but were substantially impaired in their ability to bind to 
multimeric Vn. The data suggests that multimeric vitronectin mediates protection from 
complement-mediated killing.  Therefore, vitronectin interactions that are responsible for Adr1-
mediated serum resistance are dependent on the form with which Adr1 interacts.  It is apparent 
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that the critical Adr1-vitronectin interaction that contribute to R. conorii survival in serum is much 
more complex than originally thought.  
Recent analysis of patients with confirmed cases of R. conorii infection demonstrated 
increased serum concentration of complement activation markers (Otterdal et al., 2016).  The 
logical conclusion from those studies is that R. conori infection activates complement, potentially 
leading to release of inflammatory cytokines and chemokines, and increases monocyte activation 
(Otterdal et al., 2016).  While this data may appear to be contrary to our findings, a cursory glance 
at the complement cascade demonstrates that this is not the case.  Herein and in previous 
publications, we describe rickettsial mechanisms for avoiding killing in serum.  The Adr1/Vn 
interaction simply implies that, regardless of the state of complement activation, R. conorii is able 
to prevent activation and deposition of the antibacterial terminal complement complex.  As such, 
the findings of Otterdal, et.al. dovetail with our results, because in vivo complement activation 
indicates that R. conorii must avoid complement-mediated killing in order to establish (Riley et 
al., 2012; Riley et al., 2014).  
Neisseria meningitidis is a human pathogen that causes increased morbidity and mortality 
worldwide as a result of sepsis and meningitis.  Like R. conorii, N. meningitidis has the ability to 
bind to complement regulatory proteins in order to avoid complement mediated killing. 
Specifically, this bacteria binds Factor H via factor H-binding protein to avoid deposition of C3b 
and activation of the alternative arm of the complement system (Madico et al., 2006).  When 
antibodies were created against this protein, the ability of the bacteria to bind Factor H was 
significantly decreased and as a result, the bacteria were not able to survive in serum (Madico et 
al., 2006).  This discovery lead to the development of a preventative vaccine against multiple 
strains of N. meningitidis directed against factor H-binding protein (Seib et al., 2015; Gandhi et 
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al., 2016). Herein, we demonstrate the molecular determinants of the interaction between R. 
conorii Adr1 and human Vn. The results gathered from this work further contribute to our 
understanding of the molecular mechanisms by which pathogenic rickettsial species establish 
successful infections in mammalian hosts.  Elucidation of the interacting interface(s) in Adr1 and 
vitronectin will hopefully better guide the development of novel and efficacious anti-rickettsial 
therapies that specifically target this important protein-protein interaction.  
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RICKETTSIA CONORII EXPLOITS VITRONECTIN FOR INVASION OF 




Spotted Fever Group (SFG) Rickettsia are Gram-negative obligate intracellular bacteria 
that are responsible for a number of emerging infectious diseases.  Members of this group include 
R. rickettsii and R. conorii, the etiologic agents of Rocky Mountain Spotted Fever (RMSF) and 
Mediterranean Spotted Fever (MSF), respectively (Parola et al., 2005).  These pathogens are 
transmitted to a mammalian host through tick salivary contents when an arthropod vector takes a 
blood meal (Hackstadt, 1996).  Upon inoculation into the vertebrate host, the bacteria spread 
throughout the body via the bloodstream and parasitize cells of many origins including monocytes, 
macrophages, endothelial cells and hepatocytes (Walker et al., 1994; Walker, 1997; Walker et al., 
1999; Curto et al., 2016).  Infection of endothelial cells by SFG Rickettsia can lead to disruption 
of the endothelial lining resulting in fluid leakage into the interstitial space causing the 
characteristic dermal rash (Walker and Ismail, 2008).  If left untreated, infection can result in renal 
failure, non-cardiogenic pulmonary edema, interstitial pneumonia and other multi-organ 
manifestations (Raoult and Roux, 1997). When the infection is properly identified and treated 
promptly, prognosis is good; however, misdiagnosis is common due to initial non-descript flu-like 
symptoms resulting in increased morbidity and mortality (Chan et al., 2009; Riley et al., 2014).   
Interaction of the bacterium with host cells is a critical step in the establishment of infection 
as rickettsia have evolved to be completely dependent on the nutrient rich cytoplasm of the host 
cell and are not thought to replicate extracellularly (Chan et al., 2010).  The process begins with 
recognition and adherence of the bacteria with a targeted host cell through an array of bacterial 
surface proteins and specific eukaryotic cell surface receptors.  Binding of the bacteria to a host 
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cell ligand triggers a signaling cascade within the cell which ultimately leads to bacterial 
internalization (Martinez and Cossart, 2004).  Morphologically and mechanistically this process 
resembles a zipper-like invasion strategy whereby the receptor/ligand interaction induces actin 
cytoskeleton rearrangement at the site of interaction causing “zippering” of the membrane around 
the bacterium and ultimately engulfment (Gouin et al., 1999).   
To date, a small number of rickettsial proteins have been identified that contribute to 
adherence and invasion of mammalian cells including outer membrane protein A (OmpA), outer 
membrane protein B (OmpB), surface cell antigen 1 (Sca1) and surface cell antigen 2 (Sca2) (Li 
and Walker, 1998; Martinez and Cossart, 2004; Cardwell and Martinez, 2009; Chan et al., 2009; 
Riley et al., 2010; Hillman et al., 2013).  These proteins are all members of a highly conserved 
family of genes within SFG Rickettsia termed surface cell antigens (sca) and encode for outer 
membrane proteins (Blanc et al., 2005).  Importantly, the predicted structures of the 
aforementioned proteins share homology with a family of proteins present in Gram-negative 
bacteria termed autotransporters, many of which are known virulence factors (Henderson and 
Nataro, 2001).  In R. conorii, Sca1, Sca2, OmpA and OmpB have all been demonstrated to 
facilitate adherence to non-phagocytic mammalian cells in vitro; however, only Sca2, OmpA and 
OmpB are sufficient to mediate internalization (Cardwell and Martinez, 2009; Chan et al., 2009; 
Riley et al., 2010; Hillman et al., 2013).  Previous studies have also identified the mammalian 
ligands of OmpA and OmpB as the α2β1 integrin, fibroblast growth factor receptor-1 (FGFR1) and 
Ku70 (Martinez et al., 2005; Hillman et al., 2013; Sahni et al., 2017).  Aside from these studies, 
very little is known about the identity of other mammalian proteins that can serve as receptor for 
this class of obligate intracellular bacteria. 
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Another protein expressed at the surface of R. conorii, termed Adr1, is also suggested to 
be a putative adhesion because it was demonstrated to associate with an unknown mammalian 
protein in vitro and because antibodies directed against this protein inhibited interactions with 
mammalian cells (Renesto et al., 2006; Balraj et al., 2009).  The rickettsial Adr1 proteins from 
various species of rickettsia differ in amino acid sequences but are all predicted to contain eight 
outer-membrane spanning  strands and four extracellular domains termed “loops.”  Several 
proteins that serve as adhesins in other Gram-negative bacteria are also predicted to adopt this 
structure.  A recent study on R. conorii Adr1 demonstrated that the protein interacts with the 
multifunctional human glycoprotein vitronectin (Riley et al., 2014). Vitronectin is an extracellular 
matrix protein and is important for the attachment of cells to the surrounding matrix, regulation of 
cell differentiation, proliferation and morphogenesis, and exerts regulatory function on blood 
coagulation and the complement cascade (Preissner and Seiffert, 1998).  It exists as both an 
internally folded and stabilized monomer and a partially unfolded multimer (Schvartz et al., 1999).  
Generally, monomeric vitronectin is found in high concentrations in circulating plasma while 
multimeric vitronectin is located in the extracellular matrix (Preissner and Seiffert, 1998).  
Interaction of vitronectin with different chaotropic agents and macromolecules has been described 
to induce a conformational transition from monomeric to the reactive multimeric complex (Zhuang 
et al., 1996).  Interestingly, many pathogenic bacteria, including pathogenic rickettsial species, 
have evolved mechanisms to utilize vitronectin to evade complement-mediated killing (Riley et 
al., 2014).  Further characterization of R. conorii Adr1-vitronectin interactions revealed that both 
the monomeric and multimeric form of vitronectin bound to Adr1.  This study also revealed that 
R. conorii interactions with the multimeric form and not the monomeric form of vitronectin 
correlated with protection against serum killing (Fish et al., 2017).  These findings led to further 
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investigations regarding the significance of R. conorii-monomeric vitronectin interactions in the 
infection process.  Interestingly, vitronectin can often serve as a “bridge” between pathogenic 
bacteria and target host cells in mediating adherence and invasion of target host cells (Duensing 
and van Putten, 1997; Gomez-Duarte et al., 1997; Dehio et al., 1998; Leroy-Dudal et al., 2004; 
Bergmann et al., 2009; Sa et al., 2010; Al-Jubair et al., 2015).  Therefore, it is hypothesized that 
similar to other pathogens, acquisition of monomeric vitronectin may facilitate rickettsial 
adherence and invasion into a variety of target mammalian cells.  It has previously been 
demonstrated in vivo and in vitro that pathogenic rickettsial species interact with several cell types 
including endothelial cells, circulating monocytes, neutrophils, lymphocytes and resident 
macrophages (Walker and Gear, 1985; Walker et al., 1994; Walker, 1997; Walker et al., 1999; 
Banajee et al., 2015; Curto et al., 2016; Riley et al., 2016).  Whereas several studies have 
highlighted the molecular events that govern interactions with endothelial cells, nothing is known 
about the mechanisms by which rickettsial species interact with other non-endothelial cell types.  
To model these interactions in vitro, undifferentiated THP-1, differentiated THP-1 and EA.hy cells 
representing human monocytes, macrophages and endothelial cells, respectively, were utilized.  It 
was hypothesized that initial exposure of R. conorii to vitronectin in the hematogenous circulation 
would not only be important for resistance to serum-mediating killing, but also may play a role in 
facilitating interactions with endothelial cells and circulating monocytes.  Herein, the role of 
monomeric and multimeric vitronectin binding by R. conorii in adherence and invasion of specific 
cells in in vitro models of infection was analyzed.  
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3.2 Materials and Methods 
3.2.1 Cell Lines, Rickettsia Growth and Purification 
EA.hy926 (ATCC® CRL-2922™) cells (somatic cell hybrid endothelium) were grown in 
Dulbecco’s modified Eagle’s medium (DMEM; Gibco) supplemented with 10% heat-inactivated 
fetal bovine serum (FBS) (Atlanta Biologicals), 1x non-essential amino acids (Corning) and 0.5 
mM sodium pyruvate (Corning).  THP-1 (ATCC® TIB-202™) cells (human peripheral blood 
monocytes) were grown in RPMI-1640 medium (Gibco) supplemented with 10% heat-inactivated 
fetal bovine serum.  Differentiation of THP-1 cells into macrophage-like cells was carried out by 
the addition of 100 nM of phorbol 12-myristate 13-acetate (PMA; Fisher) to 2x105 cells/mL.  Cells 
were allowed to differentiate and adhere for 3 days prior to experimentation.  All cells were 
maintained in a humidified incubator at 37°C in 5% CO2. R. conorii Malish7 was propagated in 
Vero cells and purified as previously described (Ammerman et al., 2008; Chan et al., 2009; Chan 
et al., 2011). 
3.2.2 Antibodies and Reagents 
 Anti-RcPFA rabbit polyclonal antibody that recognizes R. conorii, was generated as 
previously described (Chan et al., 2011).  Mouse anti-bovine vitronectin was purchased from 
LifeSpan Bioscience, Inc and sheep anti-human vitronectin was obtained from AbD Serotec.  
Secondary antibodies, Alexa-Fluor 488- and 546-conjugated goat anti-rabbit IgG, DAPI, and Far 
Red-X-phalloidin were purchased from Thermo Scientific.  IRDye® 680 Donkey anti-mouse IgG 
(H+L) was acquired from LI-COR Biosciences and IRDye® 800CW Donkey anti-Sheep IgG 
(H+L) was purchased from Rockland Antibodies and Assays.  Multimeric and Monomeric human 
vitronectin were purchased from Innovative Research.   
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3.2.3 Vitronectin Binding Assay 
To evaluate vitronectin adherence to the surface of each cell line: EA.hy926 cells were 
seeded into six wells of a 24-well plate at 1x105 cells/well 24 hours prior to experimentation; 
differentiated THP-1s were seeded at 2x105 cells/well 3 days prior to experimentation; and 
undifferentiated THP-1 cells were suspended in 1 mL of serum free media at a density of 2x105 
cells/mL immediately prior to experimentation. On the day of the experiment, cells were washed 
five times with PBS to remove any associated proteins from the growth media with the surface of 
the cells.  One well of each plate containing EA.hy926 or differentiated THP-1 cells were then 
exposed to either serum free media, complete media, or serum free media containing 2 or 4 μg/mL 
multimeric or monomeric vitronectin.  Undifferentiated THP-1 cells were centrifuged at 500 x g 
for 5 minutes and resuspended in each of the aforementioned treatments.  All cells were incubated 
at 34ºC with 5% CO2 for 30 minutes and then washed three times with PBS.  Adherent cells were 
lifted from the tissue culture flask by scraping in 1 mL PBS and the cells were then transferred to 
1.5 mL microcentrifuge tubes.  All cells were pelleted and total cellular lysates were prepared 
(Martinez et al., 2005).  Binding of bovine and human vitronectin was determined by SDS-PAGE 
and Western immunoblotting using mouse anti-bovine vitronectin and sheep anti-human 
vitronectin primary antibodies and donkey anti-mouse IgG 680 donkey and anti-sheep IgG 800 
secondary antibodies followed by densitometry analysis on a LI-COR Odyssey CLx system. 
3.2.4 Bacterial Association Assay 
 To assess if vitronectin binding to the cellular surface increases the ability of R. conorii to 
adhere to specific cell types, the following experimental scheme was utilized: EA.hy926 cells were 
seeded onto sterile glass coverslips (Fisher) in 24-well plates at 1x105 cells/well 24 hours prior to 
experimentation; differentiated THP-1 cells were seeded onto glass coverslips in a 24-well plate 
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at a density of 2x105 cells/well 3 days prior to experimentation; and undifferentiated THP-1s were 
suspended in 1 mL of serum free media at a density of 2x105 cells/mL prior to experimentation.  
In order to determine if cell bound vitronectin increased adherence of R. conorii to the cellular 
membrane, cells were washed five times with PBS to remove any proteins associated with the 
outer-membrane from the growth media.  Cells were then exposed to 1mL serum free media or 
serum free media contain 2 or 4 μg/mL multimeric or monomeric vitronectin and incubated for 30 
minutes at 34ºC with 5% CO2.  After 30 minutes, the cells were then washed 3 times with PBS 
and cells were infected with R. conorii at a multiplicity of infection (MOI) of 10.  The plates were 
centrifuged at 300 x g for 5 minutes at room temperature to induce bacterial contact with the cells 
and bacteria were allowed to bind for 30 minutes in a humidified incubator at 34ºC.  
Undifferentiated THP-1 cells were pelleted post vitronectin treatment and resuspended in 1 mL 
serum-free media containing R. conorii at an MOI of 10.  Cells were then incubated at 34ºC with 
agitation for 30 minutes.  All cells were washed 2 times with PBS and adherent cells were fixed 
for 20 minutes with 4% paraformaldehyde.  Undifferentiated THP-1s were mounted on slides 
using a Cytospin system and subsequently fixed.  To determine if vitronectin bound to R. conorii 
increased adherence to the cell surface, R. conorii was suspended in serum free media or serum 
free media containing 2 or 4 μg/mL of multimeric or monomeric vitronectin.  The rickettsiae were 
then incubated at 34ºC with agitation for 30 minutes. After 30 minutes, the bacteria were washed 
3 times with PBS and resuspended in 3 mL of serum-free media.  Cells were washed and 1 mL of 
each vitronectin treated R. conorii was added to each well.  The plates were centrifuged at 300 x 
G for 5 minutes and were incubated at 34ºC with 5% CO2 for 30 minutes.  Undifferentiated THP-
1 cells were resuspended in 1 mL vitronectin treated R. conorii and incubated with agitation for 
30 minutes. Cells were then washed, fixed and mounted as described above. Thereafter, infected 
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cell monolayers were processed for immunofluorescence microscopy.  Initially, cells were stained 
with rabbit anti- RcPFA at 1:1000 in 2% BSA/PBS followed by Alexa Fluor 546-conjugated goat 
anti rabbit IgG at 1:1000.  Then, cells were permeabilized with 0.1% Triton-X 100 in 2% BSA/PBS 
for 1 hour. After permeabilization, cells were stained with rabbit anti- RcPFA at 1:1000 in 2% 
BSA/PBS followed by Alexa Fluor 488-conjugated goat anti rabbit IgG at 1:1000, DAPI at 1:1000 
and Texas Red-X-phalloidin at 1:200.  Cells were then rinsed with PBS and glass coverslips were 
mounted in Mowiol semi-permanent mounting medium.  Experiments were performed in triplicate 
and the result of each experiment was expressed as the ratio of rickettsia to mammalian cells 
denoted by nuclei.  At least 200 nuclei were counted for each experiment.  Preparations were 
viewed with a Leica DM 4000b compound microscope equipped with an OLYMPUS DP80 
camera with final optical zoom of 40x.  Rickettsia were counted using the cell counter analysis 
tool from ImageJ provided by the NIH (https://imagej.nih.gov/ij/).  Adherence per cell was 
calculated as the number of rickettsia that bound the cellular membrane/number of nuclei. Percent 
invasion was calculated as extracellular rickettsia subtracted from all rickettsia to give internal 
rickettsia, which was then divided by total rickettsia. Statistical analysis was performed using a 
one-way Anova with a Dunnet’s post-hoc test. Differences were considered significant with a p-
value less than or equal to 0.05 using Graph-Pad Prism Version 5.0b (GraphPad Software). 
3.2.5 Flow Cytometry 
 Approximately 1x106 undifferentiated THP1, differentiated THP1 and EA.hy926 cells 
were washed with PBS and fixed with 4% PFA.  The expression of αVβ3 integrin on the cellular 
surface was detected using a monoclonal mouse anti- αVβ3 integrin (R&D Systems) and secondary 
Alexa Fluor 488-conjugated goat anti mouse IgG (Thermo Scientific).  Cells were analyzed with 
a FacsCaliber using FITC (488nm excitation 520/30 nm emission) and FloJo software.  
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3.3 Results 
3.3.1 Bovine vitronectin does not adhere to the cell surface, while human vitronectin binds to 
undifferentiated THP1 and EA.hy926 cells 
 
During routine culture of THP-1 and EA.hy926 cells, the cells are bathed in media 
containing heat-inactivated fetal bovine serum (FBS).  Although the serum components have been 
denatured and subsequently inactivated, it was prudent to determine if vitronectin from FBS was 
able to bind to the cellular surface of each cell line and therefore out compete human vitronectin 
for association with the cell surface. It was hypothesized that bovine vitronectin would not adhere 
to the surface of the cells because the protein had been denatured while human vitronectin would 
adhere to undifferentiated THP-1s (monocytes), differentiated THP-1s (macrophage-like), and 
EA.hy926 (endothelial) cells. To test this hypothesis cells were washed and treated with serum-
free media, complete media with FBS or serum-free media containing different concentrations of 
human monomeric and multimeric vitronectin and probed for both bovine and human vitronectin 
binding as described above.  As depicted in Figure 3.1 A-C, bovine vitronectin did not adhere to 
the surface of monocytes, macrophages or endothelial cells.  Conversely, when human vitronectin 
binding was accessed, monocytes and endothelial cells were able to bind to both multimeric and 
monomeric vitronectin, while only minimal amounts of vitronectin adhered to the surface of 
macrophages (Figure 3.2A-C).  Densitometric analysis of vitronectin interacting with host cells 
demonstrated a significant increase in the ability of monomeric vitronectin to adhere to the surface 
of monocytes while both multimeric and 4 μg of monomeric vitronectin were able to significantly 
adhere to endothelial cells (Figure 3.2D-F).  Surprising, neither multimeric nor monomeric 
vitronectin was able to significantly adhere to the surface of macrophages at the indicated 
concentrations.  Taken together, these results demonstrate that vitronectin can associate with the 
cellular surface of undifferentiated THP-1 cells and EA.hy926 cells, but not differentiated THP1 
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cells.  Therefore, analyses of putative vitronectin-mediated host cell interactions was restricted to 
EA.hy926 endothelial cells and undifferentiated THP-1 monocytes. 
  
Figure 3.1. Bovine vitronectin binding to monocytes, macrophages and endothelial cells.  
Western immunoblot analysis of bovine vitronectin binding to monocytes (A), macrophages 
(B) and endothelial cells (C) when the cells are exposed to FBS, 2 or 4 μg of monomeric (mo) 
or multimeric (mu) vitronectin (vn).  Equal loading in each experiment was verified using an 
anti-actin antibody. NHS- Normal human serum; CDMEM- complete DMEM; FBS- fetal 




3.3.2 Vitronectin binding by R. conorii increases invasion into monocytes  
 Pathogens such as Neisseria meningitidis, Pseudomonas aeruginosa and Streptococcus 
pneumoniae have been demonstrated to utilize vitronectin as a bridge to increase adherence and 
invasion of host cells and for evasion of complement mediated killing (Leroy-Dudal et al., 2004; 
Bergmann et al., 2009; Sa et al., 2010).  When rickettsiae are initially inoculated into a human host 
by an arthropod vector, the bacteria are briefly located extracellularly and likely interact with 
Figure 3.2. Human vitronectin binding to monocytes, macrophages and endothelial cells.  
Western immunoblot analysis of bovine vitronectin binding to monocytes (A), macrophages 
(B) and endothelial cells (C) when the cells are exposed to FBS, 2 or 4 μg of monomeric (mo) 
or multimeric (mu) vitronectin (vn).  Equal loading in each experiment was verified using an 
anti-actin antibody. D, E, & F. Densitometric analysis of vitronectin signal compared to actin 
control.  Data is representative of 2 replicates.  A one-way ANOVA with a Dunnet’s post hoc 
test comparing all experimental units to a single control (no vn) was performed.  * represents a 
p≤0.05 and is considered significant. NHS- Normal human serum; CDMEM- complete 
DMEM; FBS- fetal bovine serum. 
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endothelial cells of the vasculature and circulating cells such as monocytes.  We had previously 
demonstrated that R. conorii binds vitronectin in part to evade serum killing.   Therefore, we sought 
to determine if binding vitronectin would also enhance the ability of rickettsiae to adhere to and 
invade into target host cells such as monocytes and endothelial cells.  R. conorii were pre-incubated 
with two experimentally relevant concentrations of purified multimeric and monomeric 
vitronectin, then exposed the bacteria to cells for a fixed time period to allow for adherence and 
invasion.  Conversely, cells were also pre-treated with multimeric and monomeric vitronectin then 
added bacteria to the cells for the same time period to allow for adherence and invasion.  
First, the role of vitronectin was examined in adherence and invasion of undifferentiated 
THP-1 cells as an in vitro model for circulating monocytes.  When R. conorii were pre-incubated 
with 2 or 4 μg of multimeric or monomeric vitronectin, then exposed to monocytes, the ability of 
the bacteria to adhere to the cellular surface was not significantly affected as compared to the 
vitronectin-free control (Figure 3.3B).  However, the ability of the bacteria to invade the cells was 
increased in the presence of 4 μg of multimeric and monomeric vitronectin (Figure 3.3C).  
Similarly, when monocytes were pre-incubated with vitronectin then exposed to R. conorii, there 
was no significant change in the ability of the bacteria to adhere to the cell surface compared to 
the control (Figure 3.4B).  There was however, a significant increase in invasion of the bacteria in 
the presence of 2 and 4 μg of monomeric vitronectin (Figure 3.4C). Taken together this data 
demonstrates that while exogenous monomeric and multimeric vitronectin helps to facilitate the 
entry of R. conorii into monocyte-like cells, the addition of monomeric and/or multimeric 





Figure 3.3. Adherence and invasion of R. conorii pre-incubated with vitronectin then exposed 
to undifferentiated THP1 cells.  A. Representative immunofluorescence images of bacterial 
adherence and invasion assays in undifferentiated THP1 cells.  Each row demonstrates, from 
left to right, all rickettsia staining, extracellular rickettsia and actin staining, nuclei staining and 
the merged image. B. Graphical representation of the average number of rickettsia associated 
with a single cell as determined by counting a minimum of 200 nuclei for each experimental 
condition. C. Graphical representation of the percent invasion of total rickettsia associated with 
a cell as determined by counting at least 200 nuclei per experimental condition. A one-way 
ANOVA with a Dunnet’s post hoc test comparing all experimental units to a single control (no 
vn) was performed.  * represents a p≤0.05 and is considered significant. Mo- monomeric; Mu- 




Figure 3.4. Adherence and invasion of R. conorii exposed to undifferentiated THP1 cells pre-
incubated with vitronectin.  A. Representative immunofluorescence images of bacterial 
adherence and invasion assays in undifferentiated THP1 cells.  Each row demonstrates, from 
left to right, all rickettsia staining, extracellular rickettsia and actin staining, nuclei staining and 
the merged image. B. Graphical representation of the average number of rickettsia associated 
with a single cell as determined by counting a minimum of 200 nuclei for each experimental 
condition. C. Graphical representation of the percent invasion of total rickettsia associated with 
a cell as determined by counting at least 200 nuclei per experimental condition. A one-way 
ANOVA with a Dunnet’s post hoc test comparing all experimental units to a single control (no 
vn) was performed.  * represents a p≤0.05 and is considered significant. Mo- monomeric; Mu- 
multimeric; Vn- vitronectin. 
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 Endothelial cells have long been described as a primary target of rickettsial infection and 
as such it is also important to examine the role vitronectin plays in adherence and invasion of this 
cell type (Walker and Ismail, 2008). When R. conorii were pre-incubated with 2 or 4 μg of 
multimeric or monomeric vitronectin, then exposed to EA.hy926 endothelial cells, the ability of 
the bacteria to adhere to the surface of the cells increased in the presence of 4 μg monomeric 
vitronectin compared to the vitronectin-free control (Figure 3.5B). However, this increase in 
adherence did not correlate with an increase in invasion.  Instead, the ability of the bacteria to 
invade endothelial cells decreased in the presence of 4 μg multimeric vitronectin and 2 μg 
monomeric vitronectin (Figure 3.5C).  Alternatively, when endothelial cells were pre-treated with 
vitronectin then exposed to R. conorii, the ability of the bacteria to adhere to the cellular surface 
was not significantly affected compared to the control (Figure 3.6B).  Still, a decrease in the ability 
of the bacteria to invade in the presence of 4 μg monomeric vitronectin was observed.  Taken 
together, this data suggest that R. conorii are better able to adhere to the surface of endothelial 
cells when the bacteria bind a high concentration of monomeric vitronectin prior to interaction 
with the cell.  Surprisingly, the observed increase in adherence does not correlate with an increase 
in invasion.  Instead, the presence of vitronectin appears to decrease the ability of the bacteria to 





Figure 3.5. Adherence and invasion of R. conorii pre-incubated with vitronectin then exposed 
to EA.hy926 endothelial cells.  A. Representative immunofluorescence images of bacterial 
adherence and invasion assays in EA.hy926 endothelial cells.  Each row demonstrates, from 
left to right, all rickettsia staining, extracellular rickettsia and actin staining, nuclei staining and 
the merged image. B. Graphical representation of the average number of rickettsia associated 
with a single cell as determined by counting a minimum of 200 nuclei for each experimental 
condition. C. Graphical representation of the percent invasion of total rickettsia associated with 
a cell as determined by counting at least 200 nuclei per experimental condition. A one-way 
ANOVA with a Dunnet’s post hoc test comparing all experimental units to a single control (no 
vn) was performed.  * represents a p≤0.05 and is considered significant. Mo- monomeric; Mu- 





Figure 3.6. Adherence and invasion of R. conorii exposed to EA.hy926 endothelial cells pre-
incubated with vitronectin.  A. Representative immunofluorescence images of bacterial 
adherence and invasion assays in undifferentiated THP1 cells.  Each row demonstrates, from 
left to right, all rickettsia staining, extracellular rickettsia and actin staining, nuclei staining and 
the merged image. B. Graphical representation of the average number of rickettsia associated 
with a single cell as determined by counting a minimum of 200 nuclei for each experimental 
condition. C. Graphical representation of the percent invasion of total rickettsia associated with 
a cell as determined by counting at least 200 nuclei per experimental condition. A one-way 
ANOVA with a Dunnet’s post hoc test comparing all experimental units to a single control (no 
vn) was performed.  * represents a p≤0.05 and is considered significant. Mo- monomeric; Mu- 
multimeric; Vn- vitronectin. 
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3.3.3 The αVβ3 integrin is located on the surface of endothelial cells and macrophages, but not 
monocytes 
 
Differences in the ability of exogenous human vitronectin to adhere to the surface of 
monocytes, macrophages and endothelial cells (Figure 3.2A) suggested that the distribution of a 
vitronectin receptor may not be uniform among these cells types.  Therefore, the distribution of 
the primary vitronectin receptor, the αVβ3 integrin, on the surface of undifferentiated THP-1 
monocytes and EA.hy926 endothelial cells was examined.  Previously, a significant increase in 
vitronectin-mediated invasion of undifferentiated THP-1 cells was observed suggesting that these 
cells likely express more αVβ3 protein at the plasma membrane in comparison to EA.hy926 cells 
(endothelial cells).  To test this hypothesis, monocytes and endothelial cells were fixed in 
paraformaldehyde, stained with an antibody directed against αVβ3 and a fluorophore-tagged 
secondary antibody and then further processed for flow cytometry analysis.  As shown in figure 
3.7A, monocytes did not demonstrate a shift in fluorescence intensity compared to cells labeled 
with an isotype matched control antibody or secondary antibody only used as controls.  In contrast, 
this analysis revealed that endothelial cells express this receptor at the plasma membrane as 
evidenced by a shift in the fluorescence intensity (red trace; Figures 3.7B and 3.7C) when 
compared to the controls.  Taken together, the data suggests that undifferentiated THP-1 cells that 
model circulating monocytes do not express the αVβ3 integrin on the cell surface, while the integrin 




A previous report from the Martinez laboratory demonstrated that R. conorii binds 
vitronectin to evade complement mediated killing (Riley et al., 2014). Additional studies 
elucidated that both the multimeric and monomeric forms of vitronectin bound to the surface of 
the bacteria, but it was the multimer that offered protection from serum killing (Fish et al., 2017).  
The present study focused on elucidating an additional putative role for vitronectin in rickettsial 
pathogenesis by examining its contribution to adherence and invasion of R. conorii into 
monocytes, macrophages and endothelial cells.  Human vitronectin is a multi-functional human 
glycoprotein that is present in circulation and in the extracellular matrix  (Preissner and Seiffert, 
1998).  It plays a critical role in many biological processes including cell migration, tissue repair, 
adhesion, angiogenesis and regulation of membrane attack complex formation (Preissner and 
Seiffert, 1998; Singh et al., 2010b).  Vitronectin has also been implicated in the development and 
Figure 3.7. Flow Cytometric 
analysis of αVβ3 integrin 
expression on the surface of 
monocytes and endothelial cells.   
Flow cytometry demonstrated 
integrin expression on the surface 
of endothelial cells (B) by a shift 
in the red trace compared to cells 
incubated in secondary only 
(orange trace) or an isotype 
control antibody (blue trace).  No 
integrin expression was detected 
on the surface of monocytes (A) as 
depicted by the lack of shift in the 
red trace.   
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migration of some malignant tumors (Heyman et al., 2010; Pirazzoli et al., 2013; Zhu et al., 2015; 
Hao et al., 2016).  The protein is arranged in a multi-domain structure that consist of an N-terminal 
somatomedin B domain which binds plasminogen activator inhibitor-1 and an arginine, glycine, 
aspartic acid (RGD) domain that interacts with multiple integrins thus promoting attachment 
(Schvartz et al., 1999).  Vitronectin also contains three heparin binding domains and a C-terminal 
region with an unknown function, both of which have been demonstrated to bind surface proteins 
of bacterial pathogens (Blom et al., 2009; Singh et al., 2010b).  The protein can exist as a folded 
monomer or as a partially unfolded multimer through ionic interactions with itself; however, 
vitronectin in the blood circulation is predominantly found as a monomer while extravascular cell-
bound vitronectin is present as a multimer (Peterson, 1998; Schvartz et al., 1999).  Homologs to 
human vitronectin are present in many mammalian species including mice, rabbits and cows, 
although, human vitronectin contains several distinctive amino acid residues which may be 
important for bacterial and human protein/protein interactions (Leduc et al., 2009).  Because of its 
various roles, many bacterial pathogens have evolved strategies to utilize vitronectin to their 
advantage during the course of infection.  Both Gram-negative and Gram-positive pathogens 
which include Moraxella catarrhalis, Neisseria meningitidis, Pseudomonas aeruginosa, 
Haemophilus influenzae and Yersinia pestis are capable of  binding vitronectin to promote 
adherence and invasion of host cells and to protect against complement-mediated killing   (Massari 
et al., 2003; Sa et al., 2010; Singh et al., 2010a; Singh et al., 2010b; Su et al., 2013; Al-Jubair et 
al., 2015; Bartra et al., 2015; Hallstrom et al., 2015; Ikeda et al., 2015; Paulsson et al., 2015; Su et 
al., 2016).   
The results of the current study indicated that the presence of vitronectin did not affect the 
ability of R. conorii to adhere to monocytes based on the ability of the bacteria to adhere with 
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similar capabilities to the cell surface when no exogenous vitronectin was added. The fact that 
several other rickettsial ligands which include major surface cell antigens OmpA and OmpB, have 
been implicated in adherence and invasion of the bacteria to host cells further supports the 
conclusion that the bacteria does not rely on the R. conorii/vitronectin interaction to bind to 
monocytes (Chan et al., 2009; Hillman et al., 2013).  This, however, does not rule out a role for 
vitronectin in adherence.  Instead, these results suggest that further studies are needed to elucidate 
its exact contribution.  Nevertheless, the importance of the rickettsia/vitronectin/monocyte 
interaction was confirmed as the bacteria are better able to invade monocytes when vitronectin is 
present.  Because vitronectin contains separate binding sites for pathogens and host cells, it most 
likely functions as a bridge between bacteria and cells which can also promote invasion.  It has 
been reported that pathogens such as Clostridium difficile, Helicobacter pylori, and Escherichia 
coli utilize vitronectin as a bridge to better adhere to gastrointestinal epithelial cells (Ringner et 
al., 1992; Shen et al., 1995; Calabi et al., 2002)  In addition, extracellular matrix proteins including 
vitronectin have been demonstrated to be important for the attachment and invasion of the 
intracellular pathogens Chlamydia trachomatis and Burkholderia pseudomallei to host cell 
surfaces (Kihlstrom et al., 1992; Tan et al., 2017). Vitronectin acquisition not only facilitates 
binding of pathogens to host cells, but also to synthetic materials.  Staphylococcus epidermidis, 
for example, is better able to bind to polyvinylchloride (PVC) catheters in the presence of 
vitronectin. Antibodies directed against vitronectin significantly reduced the ability of the bacteria 
to adhere to the catheter when the bacteria were pre-incubated with vitronectin  (Lundberg et al., 
1997).  Vitronectin-mediated invasion is also a well-documented characteristic for some 
pathogenic bacteria.  Neisseria gonorrhea, Staphylococcus aureus and Streptococcus pneumoniae 
can better invade epithelial cells in the presence of this extracellular protein  (Chhatwal et al., 1987; 
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Gomez-Duarte et al., 1997; Dehio et al., 1998; Bergmann et al., 2009).  Interestingly, majority of 
the interactions that mediate invasion that have been characterized thus far involve entry into non-
professional phagocytes.  To my knowledge, this is the first demonstration of vitronectin mediated 
invasion of a professional phagocytic cell line.   
Similar to monocytes, addition of vitronectin did not have an impact on the ability of R. 
conorii to adhere to endothelial cells, except when the rickettsia was pre-incubated with 4 μg of 
monomeric vitronectin.  The reason for this is unclear.  Perhaps, as the bacteria are exposed to 
higher concentrations of monomeric vitronectin, the interaction increases bacterial adherence to 
this cell type in a similar manner.  In a previous study, it was demonstrated that an outer-membrane 
protein in R. conorii termed Adr1, was able to sequester both forms of vitronectin (Fish et al., 
2017).  However, resistance to serum-mediated killing was correlated with the ability of R. conorii 
to associate with the multimeric and not the monomeric form of vitronectin.  In contrast to results 
using a model of circulating monocytic cells, invasion of R. conorii into endothelial cells decreased 
in the presence of multimeric and monomeric vitronectin.  To my knowledge these results are 
unprecedented as there are currently no documented cases of a decrease in vitronectin-mediated 
bacterial invasion in the published scientific literature and most published studies have outlined 
the role(s) of vitronectin using epithelial cell lines.  Nevertheless, Neisseria meningitidis is the 
only pathogen that has been demonstrated to employ vitronectin for an increase in invasion into 
endothelial cells.  Specifically, an outer-membrane protein termed Opc, binds tyrosine residues 
exposed in the active form of vitronectin to adhere and invade human brain microvascular 
endothelium (Sa et al., 2010).  In addition, the use of the EA.hy926 cell line which is originally 
derived from human umbilical vein endothelium has been utilized in the Rickettsia community, 
but may not effectively model all Rickettsia-endothelial cell interactions observed in vivo (Edgell 
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et al., 1983; Cardwell and Martinez, 2009; Hillman et al., 2013; Yang et al., 2016).   Interestingly, 
cells derived from large and small vessel endothelium have differences in the expression of cell 
surface integrins and the patterns of expression by cultured cells are not always identical to those 
expressed in tissues (Albelda and Buck, 1990).  It is possible that vitronectin does not play a role 
in the interaction of rickettsial species with endothelial cells derived from larger vessels such as 
the umbilical vein.  As severe pathology of rickettsial infection is generally associated with 
infection of the microvascular endothelium, whether vitronectin plays a role in the interaction of 
rickettsiae with endothelial cells derived from different sources is an area that warrants further 
investigation.  
Adherence and invasion by vitronectin bound bacteria initiates when vitronectin interacts 
with the host cell surface via members of the integrin family (Preissner and Jenne, 1991).  Integrins 
are usually clustered at cell attachment sites called focal adhesion sites and mediate attachment of 
adherent cells through an internal signaling cascade and reorganization of the intracellular 
cytoskeleton network (Albelda and Buck, 1990).  Engagement with an integrin by a 
bacteria/vitronectin complex stimulates intracellular signaling molecules resulting in actin 
cytoskeletal rearrangement and can trigger bacterial uptake via a “zippering” of the host cell 
cytoplasm around the bacteria (Singh et al., 2010b).  Because it had been previously demonstrated 
that vitronectin interacts with monocytes and endothelial cells, surface expression of the primary 
vitronectin receptor, αVβ3, in these two cell types was examined.  Surprisingly, the results indicated 
that there exists little to no surface expression of this major vitronectin receptor on undifferentiated 
THP-1 cells (monocytes) while the endothelial cell line, EA.hy926, expresses a large amount of 
the αVβ3 integrin. This suggests that the αVβ3 integrin does not facilitate adherence of vitronectin 
to monocytes; however, it may play a role in vitronectin adherence to endothelial cells.  Although 
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the αVβ3 integrin has been described as the major vitronectin ligand, there are several other integrins 
that have been demonstrated to associate with this protein including α3β1, αVβ1, αVβ5 and αIIbβ3 
(Preissner and Jenne, 1991; Wei et al., 2001; Sa et al., 2010). Furthermore, both Pseudomonas 
aeruginosa and P. fluorscens have been demonstrated to adhere to A549 human lung epithelial 
cells via the αVβ5 integrin (Leroy-Dudal et al., 2004; Buommino et al., 2014).  The identification 
of vitronectin ligands on the surface of monocytes that serve as receptors for vitronectin warrants 
further investigation.  
Together, the results suggest that although the R. conorii/vitronectin interaction is 
dispensable for adherence of the bacteria to circulating monocytes and endothelial cells, it may in 
fact be a newly described mechanism by which the bacteria can attach to host cell.  Also, the results 
of this study demonstrates a secondary role for vitronectin acquisition by the bacteria in invasion 
of monocytes.  Although this work propagates many more questions, it is important because it 
contributes to our understanding of the molecular mechanisms by which pathogenic rickettsia 
species establish an infection in a mammalian host.  Future directions of this work will hopefully 
elucidate new and successful treatments of rickettsial infection, with the ultimate goal of 
developing a preventative treatment.  
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DISCUSSION OF RESULTS AND FUTURE DIRECTIONS 
 
 
4.1 Discussion of Results and Future Directions 
Because of the obligate intracellular nature of SFG Rickettsia, an intimate relationship with 
the mammalian host is necessary for the establishment of a successful infection.  Interaction with 
the host begins immediately upon inoculation of the bacterium into the mammalian host and 
continues throughout its lifecycle.  There are two important aspects to the initiation of infection: 
evasion of the host’s innate immune system; and adherence and invasion of target host cells.  
Failure results in destruction of the bacterium by the host and prevention of infection.  As a result, 
bacteria of the genus Rickettsia have evolved mechanisms to interact with the host in a manner 
that facilitates growth and survival.  The work presented here describes the contribution of an 
important interaction between R. conorii and the mammalian host that contributes to rickettsial 
pathogenesis. 
Of primary importance when studying intracellular bacteria are the mechanisms by which 
the bacteria are able to adhere to and invade target host cells as a defect, in this process is predicted 
to prevent successful infections.  To date, several proteins have been identified in SFG Rickettsia 
that are implicated in this process.  In R. conorii, OmpA, OmpB, Sca1 and Sca2 have been 
demonstrated to mediate attachment to non-phagocytic mammalian cells in vitro.  OmpA, OmpB, 
and Sca2 have also been confirmed to mediate internalization of the bacterium into epithelial and 
endothelial cells (Cardwell and Martinez, 2009; Chan et al., 2009; Riley et al., 2010; Hillman et 
al., 2013).  Interestingly, the predicted structures of these four proteins share homology with a 
family of proteins present in Gram-negative bacteria termed autotransporters (Henderson and 
Nataro, 2001).  Additionally, autotransporters from several important human pathogens including 
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Haemophilus ducreyi, Bordetella pertussis and Neisseria meningitides, play critical roles as 
virulence determinants and have also been studied as potential targets for preventative vaccine 
therapies (de Gouw et al., 2014; Fusco et al., 2015; Seib et al., 2015; Gandhi et al., 2016).  In 
addition, the causative agent of Scrub Typhus and genetically related to SFG rickettsial species, 
Orientia tsutsugamushi, expresses an autotransporter at the bacterial surface, termed ScaA, that 
has been demonstrated to provide protection from homologous and heterologous strains in a mouse 
model of infection (Ha et al., 2015).      
In SFG Rickettsia, both OmpA and OmpB have been examined for potential use as a 
vaccine candidate.  In a study examining the use of OmpA of R. rickettsii as a protective antigen, 
mice immunized with either an OmpA-expressing Mycobacterium vaccae or a DNA vaccine 
followed by a booster with homologous recombinant protein were protected from a lethal dose of 
R. conorii (Crocquet-Valdes et al., 2001).  Additionally, Chan et al. (2001) experimented with the 
use of purified recombinant R. conorii OmpB passenger domain as a potential protective antigen.  
The results indicated that immunization of mice with folded OmpB, but not linear, denatured 
peptides generated a protective immune response against a lethal challenge with R. conorii (Chan 
et al., 2011).  Interestingly, they also demonstrated that the bacteria were inherently resistant to 
complement mediated killing in the absence of neutralizing antibodies (Chan et al., 2011).  This 
was the first evidence of complement resistance for this class of bacteria leading to two questions: 
what are the rickettsial factors involved in serum resistance; and, what are their interacting 
mammalian ligands?   Using R. conorii as a model organism, Riley et al. (2012, 2014) 
demonstrated that the bacteria could sequester two complement regulatory proteins, factor H and 
vitronectin from serum, in order to subvert the host’s complement system.  The bacterial ligands 
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for factor H and vitronectin were identified as OmpB, Adr1 and Adr2, respectively (Riley et al., 
2012; Riley et al., 2014; Garza et al., 2017).   
Adr1 is a surface protein in R. conorii that is structurally related to a family of Gram-
negative outer-membrane proteins exemplified by E. coli OmpX (Vogt and Schulz, 1999). 
Members of this protein family consist of eight transmembrane β-sheets which form a pore-like 
structure through the bacterial membrane connected by four extracellular peptides loops (Jacob-
Dubuisson et al., 2004).  Interestingly, homologs to Adr1 are present in every sequenced rickettsial 
species to date and share up to 96% sequence identify in SFG species (Riley et al., 2014).  Adr1 
was first identified as a protein that associates with an unknown mammalian protein and as a result 
was termed an adhesin (Renesto et al., 2006).  Additional studies demonstrated that when 
expressed at the surface of a serum sensitive strain of E. coli, Adr1 was sufficient to confer serum 
resistance to the bacteria and sequester vitronectin (Vn) from human serum (Riley et al., 2014). 
Furthermore, expression of R. rickettsii (RR7045), R. typhi (RT815), and R. prowazekii (RP827) 
Adr1 homologs in E. coli also conferred serum resistance and vitronectin acquisition to levels 
similar to that found with R. conorii (Riley et al., 2014).  These findings were important as they 
indicated that like other intracellular and extracellular blood-borne pathogens, rickettsial species 
bind to fluid phase complement regulatory proteins for protection from complement-mediated 
killing (Chhatwal et al., 1987; Bartra et al., 2008; Ho et al., 2010; Al-Jubair et al., 2015; da Silva 
et al., 2015; Hallstrom et al., 2015; Hill et al., 2015).  Thus, the Adr1-vitronectin interaction 
represents another newly described pathogen-host interaction that may be important in 
pathogenesis. 
Biochemical analysis of the Adr1/vitronectin interface demonstrated that this 
protein/protein interface is a heparin-independent, electrostatic interaction that is mediated by the 
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C-terminal region of vitronectin (Fish et al., 2017).  Although electrostatic interactions have 
previously been established between other pathogenic bacteria and vitronectin, the Adr1-Vn 
interaction was unique because it was the first documented case of a heparin-independent, salt-
sensitive interaction in Gram-negative bacteria.  Conversely, heparin dependent, salt-sensitive 
interactions are well documented in the literature for both Gram-negative and Gram-positive 
pathogens and include proteins such as Ubiquitous surface protein A2 (UspA2) of Moraxella 
catarrhalis, Pneumococcal surface protein C (PspC) of Streptococcus pneumoniae and Protein E 
(PE) and Protein F (PF) of non-typeable Haemophilus influenzae (Singh et al., 2011; Su et al., 
2013a; Su et al., 2013b).  An additional heparin independent interaction has been identified 
between vitronectin and Meningococcal surface fibrils (Msf) of Neisseria meningitides; however, 
the dependence of electrostatic interactions has yet to be elucidated (Griffiths et al., 2011). 
Additional analysis also revealed that the Adr1-binding region of vitronectin was located in the C-
terminal region adjacent to, but not including the third heparin binding domain (Fish et al., 2017).  
However, unlike rickettsial pathogens, the majority of other bacteria have heparin-dependent 
interactions and, as a result, interact with the C-terminal heparin binding domain (Singh et al., 
2010; Singh et al., 2011; Voss et al., 2013; Hallstrom et al., 2016).   Although the Adr1/vitronectin 
interaction is similar in some aspects, it is different than other bacterial/vitronectin interactions 
and is likely unique to rickettsial species. 
In mutagenesis studies where single loop domains of Adr1 were expressed in a serum 
sensitive strain of E. coli, Riley et al. (2014) demonstrated that “loops 3” (amino acids 160-186) 
and “loop 4” (amino acids 210-228) provided serum resistance for the bacteria, suggesting that 
these loops mediate an interaction with vitronectin.  Interestingly, these two peptide loops contain 
a high concentration of positively charged polar lysine residues and it was hypothesized that the 
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charged nature of these loops facilitates the interaction between Adr1 and vitronectin.  Initially, 
single lysines within each loop were substituted for an uncharged non-polar alanine residue and 
the resulting protein was expressed in a serum sensitive strain of E. coli then exposed to human 
serum.  The results demonstrated that a single lysine to alanine substitution at any position within 
loop 3 or 4 did not significantly affect the ability of the bacteria to survive serum killing (Fish et 
al., 2017).  This data suggested that a single lysine residue was likely not important in mediating 
the electrostatic interaction between Adr1 and vitronectin; rather, it was hypothesized that the 
interplay between the proteins was mediated by the total positive charge of the loops.  Additional 
Adr1 mutants were constructed that had sequential lysine to alanine substitutions at the first two 
positions, first three positions, first four position and continued until all six lysines had been 
mutated in each loop.  Examination of the ability of E. coli expressing these Adr1 mutants to evade 
serum killing revealed that substitution of the first two or more lysines to non-charged alanine 
residues resulted in sensitivity to complement mediated killing when exposed to normal human 
serum.  This indicates that the first two lysines in loops 3 and 4 are critical in mediating resistance 
to serum killing; however, this initial finding did not exclude the possibility that the net charge of 
each loop contributes to the observed phenotype (Fish et al., 2017).  To test this possibility, 
additional double lysine mutants were constructed at lysine position 1 and 5 or at positions 5 and 
6 within the Adr1 “loop 3” and then tested for their ability to survive exposure to human serum.   
The results demonstrated that these double lysine mutants remained resistant to serum-mediated 
killing suggesting that the net total charge of the loop is not critical in mediating the interaction of 
Adr1 with vitronectin.  Instead, the results indicate that the first two lysines in loops 3 and 4 are 
critical in mediating the Adr1-vitronectin interactions which correlates with the ability of these 
bacteria to avoid serum killing (Fish et al., 2017).  
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 Other electrostatic interactions have been described in the literature including the 
PspC/vitronectin interaction of S. pneumoniae.  Although the individual amino acids responsible 
have not been identified, researchers speculate that the negatively charged amino acids of the R 
domain mediate this interaction (Voss et al., 2013).  Also, a positively charged polar arginine 
residue has been demonstrated to be important in the interaction of vitronectin with PE of non-
typeable H. influenzae (Singh et al., 2011).  Although structurally unrelated, PspC and PE are 
similar to Adr1 in that these proteins are associated with the outer-membrane and have several 
domains exposed to the extracellular environment.  Similar to PspC and PE interaction with 
vitronectin, the interaction between Adr1 of R. conorii and vitronectin is electrostatic in nature and 
appears to rely on the first two positively charged lysine residues within loops 3 and 4.  These 
lysine residues in each loop are predicted to create a critical initial interaction domain that then 
facilitates the stabilization of the Adr1-vitronectin interaction.  Taken together, it is probable that 
the overall structure of Adr1 plays an important role in this protein/protein interaction.  As depicted 
in figure 4.1, it is highly likely that the first 2 lysine residues within both loops are closely 
associated in the overall tertiary structure of Adr1 and that the cumulative effect of these 4 lysines 
together creates the critical microdomain for the Adr1-vitronectin interaction.  Although the first 
two lysine residues in loop 3 or 4 alone are sufficient to mediate this interaction, it was speculated 
that the interaction between intact Adr1 and vitronectin is much stronger than the interaction 
between a single loop and vitronectin.  
Vitronectin is a multi-functional human glycoprotein that is a part of the extracellular 
matrix and can be found in plasma.  It exists as both an internally folded and stabilized monomer, 
also called the native form, and a partially unfolded, functionally active multimer which can also 
be referred to as the active confirmation (Preissner and Seiffert, 1998).  Within human plasma, 
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vitronectin is predominantly found as a circulating monomer with a small quantity found in the 
multimeric configuration.  Conversely, extravascular vitronectin is primarily multimeric and cell 
bound.  (Stockmann et al., 1993).  Interaction of vitronectin with different chaotropic agents, 
detergents, heat or macromolecules including the membrane attack complex, has been associated 
with conformational transition from the monomeric form to the reactive multimeric complex 
(Hogasen et al., 1992; Stockmann et al., 1993).   
In the process of correlating vitronectin acquisition with serum survival of Adr1 mutants, 
it was discovered that Adr1 can interact with the monomeric and multimeric forms of vitronectin.  
However, a recent study determined that the multimer offered protection of the Adr1-expressing 
E.coli from serum killing, leaving the role of monomeric vitronectin undefined (Fish et al., 2017).  
Figure 4.1. The predicted structure of R. conorii Adr1 with a spacefill representation of the first 
2 lysine residues in loops 3 and 4. The Adr1 model demonstrates a pore-like structure with 8 
transmembrane beta sheets (yellow) and 4 extracellular peptide “loop” domains (red).  The 
purple represents a space fill model of the first 2 lysines in “loops” 3 and 4. 
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It is well-documented that both Gram-negative and Gram-positive bacterial pathogens can 
sequester vitronectin for evasion of serum killing and to facilitate adherence and invasion of host 
cells (Singh et al., 2010).  These interactions are thought to be governed by the interactions of 
bacteria with different forms of vitronectin.  For example, Yersinia pestis utilizes 2 outer 
membrane proteins Ail and Pla, to bind and process the native monomeric form of vitronectin, 
which is necessary to facilitate complement evasion (Bartra et al., 2008; Bartra et al., 2015).  
Neisseria meningitides preferentially interacts with the active form of vitronectin for protection 
from complement mediated attack and to facilitate entry into human brain microvascular 
endothelial cells (Dehio et al., 1998; Sa et al., 2010). Also, the respiratory pathogens, Haemophilus 
influenzae and Streptococcus pneumoniae, can utilize vitronectin to attach to pulmonary epithelial 
cells (Bergmann et al., 2009; Al-Jubair et al., 2015).  Therefore, the possibility that the 
vitronectin/R. conorii interaction could also mediate attachment and invasion of target host cells 
was investigated. 
In studies examining the role of vitronectin in adherence and invasion of monocytes and 
endothelial cells, addition of exogenous vitronectin did not affect the ability of the bacteria to 
adhere to the surface of the cell.  This was not an unexpected result as previous reports have 
documented other rickettsial ligands including OmpA and OmpB, mediate adherence and 
internalization of non-phagocytic cells (Li and Walker, 1998; Cardwell and Martinez, 2009; Chan 
et al., 2009; Riley et al., 2010; Hillman et al., 2013).  In these studies, competitive inhibition of 
Rickettsia-host cell interactions by individual purified recombinant Sca proteins was disrupted but 
not completely eliminated in vitro suggesting that other conserved factors may compensate for 
binding to and invasion of host cells (Cardwell and Martinez, 2009; Chan et al., 2011).  In addition, 
the presence of vitronectin increased the ability of rickettsia to invade monocytes and decreased 
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the ability of the bacteria to invade endothelial cells.  Even though this data is contradictory, these 
results could potentially be a result of a difference in the expression of rickettsial ligands on the 
surface of different mammalian cell types.  Current knowledge of identified receptor/ligand pairs 
indicates that not all pairs mediate both adherence and internalization.  Sca1 of R. conorii, for 
example, can mediate attachment of rickettsia to host cells, however it does not facilitate invasion 
(Riley et al., 2010).  Because the presence of vitronectin decreases invasion into endothelial cells, 
it is possible that interaction of the R. conorii/Vn complex with the surface of EA.hy926 
endothelial cells does not mediate invasion.  Additionally, interaction of the bacteria with 
vitronectin could mask other receptor/ligand pairs that do facilitate uptake into this particular cell 
type.  Although it is well documented that various bacterial pathogens including Neisseria 
gonorrhea, Staphylococcus aureus, Burkholderia pseudomallei and Klebsiella pneumoniae utilize 
vitronectin to enhance invasion of target host cells, to my knowledge, this is the first documented 
case of vitronectin reducing the ability of a pathogen to invade a cell (Chhatwal et al., 1987; 
Gomez-Duarte et al., 1997; Dehio et al., 1998; Tan et al., 2017).  It is important to note that large 
and small vessel endothelium have differences in integrin expression and endothelial cells in vitro 
may not faithfully model the receptor distribution of cells in tissues (Albelda and Buck, 1990).  
Therefore, additional factors could potentially play a role in adherence and invasion of endothelial 
cells by rickettsia that are not effectively replicated by this in vitro system.  Whereas most studies 
describing the role of vitronectin in bacterial adherence have focused on interactions with epithelial 
and endothelial cells, to my knowledge, this is the first description of vitronectin-mediated 
invasion of a professional phagocytic cell line.  
Adherence to and invasion of host cells by rickettsiae that have sequestered fluid phase 
vitronectin is predicted to begin by binding to members of the integrin family.  A plethora of 
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integrins have been associated with vitronectin including, the major vitronectin receptor, αVβ3, in 
addition to α3β1, αVβ1, αVβ5, αIIbβ3 (Preissner and Jenne, 1991; Wei et al., 2001; Sa et al., 2010).  
When vitronectin interacts with an integrin an internal signaling cascade is triggered that results 
in actin cytoskeletal rearrangement and ultimately uptake of the bacteria via a “zippering” 
mechanism (Singh et al., 2010).  Because it had previously been demonstrated that vitronectin 
could interact with the surface of both monocytes and endothelial cells, it was hypothesized that 
the major vitronectin receptor, αVβ3, would be present on the surface of both cell types.  Upon 
examination, the αVβ3 integrin was demonstrated to be found at a high concentration on the surface 
of endothelial cells but was not located on the surface of monocytes.  This suggests that the αVβ3 
integrin may play a role in vitronectin adherence to endothelial cells, whereas another integrin 
likely mediates the interaction between vitronectin and monocytes. Interestingly, the bacterial 
pathogens Pseudomonas aeruginosa and P. fluorscens utilize the αVβ5 integrin to adhere to A549 
human lung epithelial cells in a vitronectin-dependent mechanism, demonstrating that other 
integrins can indeed function to bind vitronectin and enhance pathogen-host cell interactions 
(Leroy-Dudal et al., 2004; Buommino et al., 2014).  Currently, the identity of the vitronectin 
ligand(s) on the surface of monocytes that are utilized for rickettsial pathogens remains to be 
elucidated and is the subject of future lines of investigation in the Martinez laboratory. 
Taken together these results demonstrate that vitronectin plays an important role in the 
initial stages of rickettsial infection.  This body of work has demonstrated that an interaction 
between multimeric vitronectin and R. conorii Adr1 provides protection of the bacterium from 
complement mediated killing and the interaction between the two proteins has been characterized.  
Also, this work has established a role for vitronectin acquisition by rickettsia in invasion of the 
bacteria in monocytes and endothelial cells, albeit detrimental in the latter.  Future work from this 
96 
study should include exploration of the detailed mechanisms of the vitronectin/bacterium 
interaction with both phagocytic and non-phagocytic host cells and should include exploration of 
the internal signaling machinery responsible for bacterial uptake.  Of primary importance is the 
need to elucidate the host cell receptor for vitronectin on the surface of monocytes.  One integrin, 
αVβ3, likely does not participate in this interaction; however, there are a number of other candidate 
proteins to investigate and the identification of the receptor would further the understanding of 
how pathogenic rickettsia species interact with phagocytic cells.  The Martinez lab has previously 
identified two outer-membrane proteins of R. conorii, Adr1 and Adr2, that serve as bona fide 
vitronectin interacting proteins.  It would be useful to define the contribution of Adr1 and Adr2 in 
vitronectin-mediated adherence and invasion of monocytes and endothelial cells.  Interestingly, 
the predicted extracellular loop domains of both Adr1 and Adr2 are very different at the amino 
acid level and these differences may contribute to differences in protein function.  Proposed studies 
would, therefore, help to determine if Adr1 and Adr2 are truly similar proteins with redundant 
functions or if they each have a specific role in vitronectin mediated pathogenesis of the bacteria. 
Interestingly, Gong et al. (2014) demonstrated that C3H/HeN mice immunized with recombinantly 
expressed Adr2 of R. rickettsii were able to survive a lethal challenge with R. rickettsii (Gong et 
al., 2014).  Additionally, another human bacterial pathogen, Neisseria meningitidis, expresses a 
factor H-binding protein that has been used a protective antigen in the Meningococcal B subunit 
vaccine (Gorringe and Pajon, 2012; Gandhi et al., 2016).  This suggests that complement binding 
proteins of pathogenic bacteria, including proteins such as R. conorii Adr1, could potentially be 
targets of preventative vaccine therapy.   
Additionally, future studies detailing the signaling events involved in the entry of the 
vitronectin/rickettsia complex into phagocytic mammalian cells would be beneficial because it is 
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clear that infection of phagocytes is an important, yet under-appreciated aspect of rickettsial 
biology.  A recent study demonstrated that the human pathogen, R. conorii, can survive and 
proliferate within the cytoplasm of differentiated THP-1 macrophage-like cells. Conversely, a non-
virulent member of the SFG Rickettsia, R. montanensis, demonstrated a severe deficient in growth 
and survival in this cell type (Curto et al., 2016).  This suggests that differences in the ability of 
rickettsia species to survive within the cytoplasm of phagocytic cells may explain the differences 
in pathogenicity.  Furthermore, the current body of work indicates that there are at least two 
mechanisms by which pathogenic rickettsia can invade undifferentiated THP1 monocytes.  There 
is a vitronectin dependent and a vitronectin independent pathway as indicated by the ability of R. 
conorii to successfully invade monocytes when no vitronectin was present. With emerging 
evidence to support the role of monocytes and macrophages as important cellular targets of 
infection, it will also be necessary to explore the detailed mechanisms by which the bacteria adhere 
and invade this cell type.   
This work has provided a further understanding at the molecular level of how an obligate 
intracellular bacterial pathogen usurps host protein function for its own survival, growth and 
subsequent spread.  In addition, this work provides further insight regarding how an organism with 
a small genome (1.2Mb) has evolved to take full advantage of its limited amount of resources, by 
expressing multi-functional proteins.  Overall, the data here contributes to our understanding of 
the molecular mechanisms by which pathogenic Rickettsia species evade killing and establish an 
infection in a mammalian host but has also generated many more questions regarding the 
mechanisms by which rickettsial species and potentially other obligate intracellular bacteria 
initiate successful colonization of hosts.  Future work in this area will hopefully enable the 
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development of novel therapeutic treatments for pathogenic rickettsial infections with the ultimate 
goal of developing a preventative treatment.  
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APPENDIX A. TABLE OF PRIMER SEQUENCES USED IN MUTAGENESIS 
 
 
Primer Sequences   
   
Corresponding 
plasmid name 






K160A- Reverse 5'-AATTTTTTCCGCTACAAAAGCAGCACCAAC-3' 
K160A- Screening 5'-GTTGGTGCTGCTTTTGTAGCG-3' 
AF2 
K162A- Forward 5'-GTAAAGGAAGCGATTCACTCTAAAGATATTAAAGGTGG-3' 
K162A- Reverse 5'-AGAGTTAATCGCTTCCTTTACAAAAGCAGCACC-3' 
K162A- Screening 5'-GCTGCTTTTGTAAAGGAAGCG-3' 
AF3 
K166A- Forward 5'-ATTCACTCTGCGGATATTAAAGGTGGTGTAACTGAC-3' 
K166A- Reverse 5'-TTTAATATCCGCAGAGTGAATTTTTTCCTTTACAAAAGC-3' 
K166A- Screening 5'-AAGGAAAAAATTCACTCTGCG-3' 
AF4 
K169A- Forward 5'-AAAGATATTGCGGGTGGTGTAACTGACACTTTC-3' 
K169A- Reverse 5'-TACACCACCCGCAATATCTTTAGAGTGAATTTTTTCCTTTAC-3' 
K169A- Screening 5'-GAAAAAATTCACTCTAAAGATATTGCG-3' 
AF5 
K181A- Forward 5'-GGTACTACTGCGAACAAAACTAACTTTGCTTATCAATTATC-3' 
K181A- Reverse 5'-AGTTTTGTTCGCAGTAGTACCGTTGAAAGTGTC-3' 
K181A- Screening 5'-ACTTTCAACGGTACTACTGCG-3' 
AF6 
K183A- Forward 5'-ACTAAAAACGCGACTAACTTTGCTTATCAATTATCTTTAGG-3' 
K183A- Reverse 5'-AAAGTTAGTCGCGTTTTTAGTAGTACCGTTGAAAGTG-3' 





   
 
Individual Loop 4 
mutants  
AF7 
K215A- Forward 5'-GATTACGGTGCGACAAAAAATACCACCAAAACTATTAAC-3' 
K215A- Reverse 5'-GTATTTTTTGTCCGCACCGTAATCTCTCCAGCTATAAAC-3' 
K215A- Screening 5'-CTGGAGAGATTACGGTGCG-3' 
AF8 
K217A- Forward 5'-GGTAAAACAGCGAATACCACCAAAACTATTAACGGG-3' 
K217A- Reverse 5'-GGTGGTATTCGCTGTTTTACCGTAATCTCTCCAG-3' 
K217A- Screening 5'-GAGATTACGGTAAAACAGCG-3' 
AF9 
K221A- Forward 5'-AATACCACCGCGACTATTAACGGGGATAAAGTTAAATTT-3' 
K221A- Reverse 5'-GTTAATAGTGCGGGTGGTATTTTTTGTTTTACCG-3' 
K221A- Screening 5'-GTAAAACAAAAAATACCACCGCG-3' 
AF10 
K227A- Forward 5'-AACGGGGATGCGGTTAAATTTGGTGGAACCCATTATAAAG-3' 
K227A- Reverse 5'-AAATTTAACCGCATCCCCGTAATAGTTTTGGTG-3' 
K227A- Screening 5'-CAAAACTATTAACGGGGATGCG-3' 
AF11 
K229A- Forward 5'-GATAAAGTTGCGTTTGGTGGAACCCATTATAAAGGTC-3' 
K229A- Reverse 5'-TCCACCAAACGCAACTTTATCCCCGTTAATAG-3' 
K229A- Screening 5'-ATTAACGGGGATAAAGTTGCG-3' 
AF52 
K236A- Forward 5'-ACCCATTATGCGGGTCATAACTTAATGGCAGG-3' 
K236A- Reverse 5'-GTTATGACCCGCATAATGGGTTCCACCAAATTTAAC-3' 





   
 
Multiple mutants in  
Loop 3  
AF13 
pL3M2- Forward 5'-GTAGCGGAAGCGATTCACTCTAAAGATATTAAAGGTGG-3' 
pL3M2- Reverse 5'-GAGTGAATCGCTTCCGCTACAAAAGCAGC-3' 
pL3M2- Screening 5'-GCTTTTGTAGCGGAAGCG-3' 
AF14 
pL3M3-Forward 5'-ATTCACTCTGCGGATATTAAAGGTGGTGTAACTGAC-3' 
pL3M3- Reverse 5'-CTTTAATATCCGCAGAGTGAATCGCTTCCGCTAC-3' 
pL3M3- Screening 5'-GCGGAAGCGATTCACTCTGCG-3' 
AF15 
pL3M4- Forward 5'-GCGGATATTGCGGGTGGTGTAACTGACACTTTG-3' 
pL3M4- Reverse 5'-GTTACACCACCCGCAATATCCGCAGAGTGAATCGC-3' 
pL3M4- Screening 5'-GATTCACTCTGCGGATATTGCG-3' 
AF16 
pL3M5- Forward 5'-GGTACTACTGCGAACAAAACTAACTTTGCTTATCAATTATC-3' 
pL3M5- Reverse 5'-AGTTTTGTTGCGAGTAGTACCGTTGAAAGTGTC-3' 
pL3M5- Screening 5'-CTTTCAACGGTACTACTGCG-3' 
AF25 
pL3M6- Forward 5'-ACTGCGAACGCGACTAACTTTGCTTATCAATTATCTTTAG-3' 
pL3M6- Reverse 5'-CAAAGTTAGTCGCGTTCGCAGTAGTACCGTTG-3' 
pL3M6- Screening 5'-AACGGTACTACTGCGAACGCG-3' 
AF53 
K181A- Forward 5'-GGTACTACTGCGAACAAAACTAACTTTGCTTATCAATTATC-3' 
K181A- Reverse 5'-AGTTTTGTTCGCAGTAGTACCGTTGAAAGTGTC-3' 
K181A- Screening 5'-ACTTTCAACGGTACTACTGCG-3' 
AF55 
K181,183A- Forward 5'-GGTACTACTGCGAACGCGACTAACTTTGCTTATCAATTATC-3' 
K181,183A- Reverse 5'-AGTCGCGTTCGCAGTAGTACCGTTGAAAGTGTC-3' 





   
 
Multiple mutants in  
Loop 4  
AF17 
pL4M2- Forward 5'-GGTGCGACAGCGAATACCACCAAAACTATTAACGGG-3' 
pL4M2- Reverse 5'-GGTGGTATTCGCTGTCGCACCGTAATCTCTC-3' 
pL4M2- Screening 5'-GATTACGGTGCGACAGCG-3' 
AF24 
pL4M3-Forward 5'-AATACCACCGCGACTATTAACGGGGATAAAGTTAAATTT-3' 
pL4M3- Reverse 5'-GTTAATAGTCGCGGTGGTATTCGCTGTCGC-3' 
pL4M3- Screening 5'-ACAGCGAATACCACCGCG-3' 
AF26 
pL4M4-Forward 5'-AACGGGGATGCGGTTAAATTTGGTGGAACCCATTATAAAG-3' 
pL4M4- Reverse 5'-AAATTTAACCGCATCCCCGTTAATAGTCGC-3' 
pL4M4- Screening 5'-GACTATTAACGGGAATGCG-3' 
AF28 
pL4M5- Forward 5'-GATGCGGTTGCGTTTGGTGGAACCCATTATAAAGG-3' 
pL4M5- Reverse 5'-TCCACCAAACGCAACCGCATCCCCGTTAATAG-3' 
pL4M5- Screening 5'-AACGGGGATGCGGTTGCG-3' 
AF29 
pL4M6- Forward 5'-ACCCATTATGCGGGTCATAACTTAATGGCAGG-3' 
pL4M6- Reverse 5'-GTTATGACCCGCATAATGGGTTCCACCAAACGC-3' 
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